{"meta":{"query_hash":"ceb70015add6","filters":{"venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical"},"cohort_total":84,"direct_labels_cover":0,"predictions_cover":84,"exported":84,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/ceb70015add6","api":"https://metacan.xera.ac/api/v1/cohort?venue=Multiple+Sclerosis+Journal+-+Experimental+Translational+and+Clinical"},"results":[{"id":"W1825100754","doi":"10.1177/2055217315596532","title":"Association of plasma levels of Protein S with disease severity in multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Neurosciences Foundation; Royal Melbourne Hospital Neuroscience Foundation; Hospital Research Foundation; Ministère de la Santé et des Services sociaux; Neurosciences Research Foundation","keywords":"MERTK; Multiple sclerosis; Cohort; Disease; Medicine; Internal medicine; Oncology; Immune system; Immunology; Clinically isolated syndrome; Receptor; Case-control study; Innate immune system; Receptor tyrosine kinase","score_opus":0.15821249407229257,"score_gpt":0.30927449500461335,"score_spread":0.15106200093232078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1825100754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99937314,0.0003397936,0.00006404287,0.000014217539,0.0000022360132,0.0000020616374,0.00007713281,0.0000058649084,0.00012154929],"genre_scores_gemma":[0.9996747,0.000067149354,0.00009405081,0.0000064694536,0.0000046918253,0.000002251845,0.00008463084,0.0000011005619,0.00006510095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981683,0.000049489412,0.00003189985,0.000047563466,0.000035910525,0.000018350856],"domain_scores_gemma":[0.9985662,0.00027210216,0.0007930361,0.0000556177,0.00010866335,0.00020439457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038277547,0.00030611758,0.0002877964,0.0008467457,0.0002117749,0.00031978596,0.00014238039,0.00038550515,0.0014207629],"category_scores_gemma":[0.0011431136,0.00015595857,0.00017252253,0.00056405074,0.00025342443,0.00021182113,0.00023199123,0.000300809,0.00018021469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011441557,0.00004362415,0.990644,0.000025958603,0.00008632962,0.00011743997,0.00005000117,0.00006404971,0.0055283904,0.000010945696,0.000052607877,0.0022325877],"study_design_scores_gemma":[0.0000083360865,0.0003199145,0.99842876,0.0000031773325,0.000023322391,0.00051049405,0.000031347696,0.00014973902,0.00044422725,0.00002142509,0.000057166544,0.000002186689],"about_ca_topic_score_codex":0.00045047764,"about_ca_topic_score_gemma":0.00036895703,"teacher_disagreement_score":0.0014207629,"about_ca_system_score_codex":0.00011477369,"about_ca_system_score_gemma":0.00009452767,"threshold_uncertainty_score":0.004752934},"labels":[],"label_agreement":null},{"id":"W2126609777","doi":"10.1177/2055217315585333","title":"Adherence to behavioural interventions in multiple sclerosis: Follow-up meeting report (AD@MS-2)","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Psychological intervention; Psychosocial; Physical activity; Multiple sclerosis; Intervention (counseling); Psychology; Medicine; Clinical psychology; Gerontology; Physical therapy; Psychiatry","score_opus":0.5241701693713542,"score_gpt":0.44977806851876634,"score_spread":0.07439210085258785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126609777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618285,0.0018427273,0.0012648258,0.0046068556,0.0006825196,0.0032577463,0.015855419,0.0004115156,0.010249829],"genre_scores_gemma":[0.9483228,0.0016078177,0.007859101,0.0032622803,0.0006787605,0.008379036,0.019041907,0.00009558661,0.010752761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972588,0.0010348653,0.00068719295,0.00018534197,0.00060923275,0.00022456986],"domain_scores_gemma":[0.98658794,0.002629951,0.0043150513,0.000869924,0.0038692947,0.0017278831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008139516,0.00038179077,0.0006267928,0.0018189072,0.0013211954,0.0008066461,0.0007288258,0.0014548101,0.0019264558],"category_scores_gemma":[0.015304694,0.0003709787,0.0009398315,0.0007912713,0.0001426685,0.0007499022,0.0014690757,0.00219469,0.0011715072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027664553,0.004877108,0.7027834,0.0014048651,0.00065898284,0.0010086005,0.0063622007,0.0003082786,0.0030572584,0.00016918294,0.039715968,0.23688772],"study_design_scores_gemma":[0.00034954128,0.0028636346,0.9783101,0.00025005187,0.00024138932,0.00039951128,0.0015587228,0.0006076898,0.001657765,0.000085593936,0.013579905,0.00009616273],"about_ca_topic_score_codex":0.0062390086,"about_ca_topic_score_gemma":0.008249261,"teacher_disagreement_score":0.008139516,"about_ca_system_score_codex":0.00090170145,"about_ca_system_score_gemma":0.00069898897,"threshold_uncertainty_score":0.043046415},"labels":[],"label_agreement":null},{"id":"W2167256476","doi":"10.1177/2055217315577829","title":"Personalized activity index, a new safety monitoring tool for multiple sclerosis clinical trials","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"Medicine; Guideline; Multiple sclerosis; Clinical trial; Post-hoc analysis; Internal medicine; Oncology; Pathology; Psychiatry","score_opus":0.6189445089244806,"score_gpt":0.5053682196332013,"score_spread":0.11357628929127928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167256476","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25176644,0.11699811,0.404846,0.02282842,0.0033451545,0.035475235,0.054122996,0.022715978,0.08790165],"genre_scores_gemma":[0.5546378,0.010425909,0.39406502,0.003860598,0.0016044719,0.020716768,0.010982109,0.00057279336,0.0031346057],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.8851601,0.0675537,0.024816012,0.002719643,0.019306062,0.0004445671],"domain_scores_gemma":[0.687402,0.16875908,0.09451242,0.010622932,0.03493943,0.0037641793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0892236,0.0011896929,0.002845877,0.008035099,0.0005822595,0.0042708577,0.0016244913,0.0015187243,0.0026487529],"category_scores_gemma":[0.22987461,0.00069489726,0.0021756722,0.005830008,0.0005193155,0.0035474254,0.0017005313,0.001691316,0.0011769129],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009538279,0.00038275725,0.21732688,0.010143704,0.0052055684,0.0002672441,0.0008219138,0.004507139,0.0024650763,0.0028153304,0.054211926,0.6923141],"study_design_scores_gemma":[0.008761939,0.012673962,0.6668861,0.007664487,0.013356718,0.003974286,0.00066872296,0.06911043,0.010631622,0.013736808,0.19185346,0.00068150344],"about_ca_topic_score_codex":0.00050831784,"about_ca_topic_score_gemma":0.0014527467,"teacher_disagreement_score":0.0892236,"about_ca_system_score_codex":0.001603454,"about_ca_system_score_gemma":0.0034962413,"threshold_uncertainty_score":0.47186512},"labels":[],"label_agreement":null},{"id":"W2200581100","doi":"10.1177/2055217315600193","title":"Multiple sclerosis in Latin America: A different disease course severity? A collaborative study from the MSBase Registry","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Cégep de Lévis; Hôpital Charles-Le Moyne; Hôpital Notre-Dame","funders":"EMD Serono; H. Lundbeck A/S; Novartis Pharma; Multiple Sclerosis Society; Sanofi; Guthy-Jackson Charitable Foundation; Canadian Institutes of Health Research; Ministère de la Santé et des Services sociaux; Teva Pharmaceutical Industries; Biogen","keywords":"Multiple sclerosis; Latin Americans; Medicine; Demography; Disease; Internal medicine; Psychiatry","score_opus":0.23030205205927265,"score_gpt":0.3950978019146475,"score_spread":0.16479574985537485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2200581100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484396,0.00081290613,0.00019284997,0.00028645992,0.0000133341755,0.00006087601,0.0016219452,0.000011846594,0.0021558465],"genre_scores_gemma":[0.995523,0.0005572702,0.00023604947,0.00026095324,0.000036079862,0.000112249465,0.0030713752,0.00001784884,0.00018524325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967505,0.0016871378,0.00041153122,0.0004938134,0.00037088725,0.00028622718],"domain_scores_gemma":[0.99210703,0.0015327026,0.0033809086,0.0011702363,0.0011918773,0.00061726547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005535918,0.00041160514,0.0009391722,0.0019292339,0.00079437037,0.0018351191,0.0005553365,0.00048633997,0.0015500897],"category_scores_gemma":[0.009794554,0.00032797022,0.0008090976,0.004825019,0.00043703645,0.0012491827,0.0013515977,0.0004969967,0.00032719353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022006748,0.000026866113,0.9970139,0.000025642672,0.000118967626,0.00007659051,0.0003296504,0.000021589609,0.000063158346,0.000021908922,0.0003006417,0.0017808194],"study_design_scores_gemma":[0.000087909764,0.00008538272,0.99672616,0.000053586988,0.00019622478,0.00034020038,0.0011616279,0.00007914381,0.000031568994,0.000033033826,0.0011956651,0.000009513515],"about_ca_topic_score_codex":0.027629485,"about_ca_topic_score_gemma":0.02935839,"teacher_disagreement_score":0.027629485,"about_ca_system_score_codex":0.00092378503,"about_ca_system_score_gemma":0.0010427003,"threshold_uncertainty_score":0.054937363},"labels":[],"label_agreement":null},{"id":"W2243670870","doi":"10.1177/2055217315589775","title":"Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Centre Hospitalier de l’Université de Montréal; Foothills Medical Centre; McGill University Health Centre; St. Michael's Hospital; University of British Columbia; University of Ottawa; Montreal Neurological Institute and Hospital","funders":"Canadian Institutes of Health Research; Novartis Pharmaceuticals Canada; Multiple Sclerosis Society of Canada; Vertex Pharmaceuticals; Teva Pharmaceutical Industries","keywords":"Medicine; Multiple sclerosis; Magnetic resonance imaging; Neuroimaging; Radiological weapon; Atrophy; Radiology; Pathology; Psychiatry","score_opus":0.2636027957651652,"score_gpt":0.3891455065218893,"score_spread":0.12554271075672407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2243670870","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019187828,0.25885004,0.0053793276,0.68663234,0.0146063855,0.0015289375,0.0033375293,0.00020532194,0.027541341],"genre_scores_gemma":[0.053934705,0.5301225,0.16362964,0.21997795,0.0065472154,0.0029763517,0.008984338,0.00023371512,0.0135935685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9715225,0.0072688065,0.005747687,0.0012261859,0.012143798,0.0020910217],"domain_scores_gemma":[0.8631446,0.013475493,0.0052831993,0.0013362224,0.10793403,0.008826397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04327971,0.0017214655,0.0023648131,0.0076418836,0.00423379,0.0052082115,0.010236304,0.009182507,0.0044076312],"category_scores_gemma":[0.09538197,0.001068402,0.0041984203,0.0080995895,0.0028366123,0.0031541458,0.0034918713,0.010705619,0.0014747321],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013353104,0.00011074145,0.0036043772,0.0142989885,0.00048650827,0.00042404965,0.0011337653,0.0016536841,0.0003605477,0.009261221,0.6913917,0.27714092],"study_design_scores_gemma":[0.00035290653,0.00007143325,0.007940185,0.064102046,0.0012846322,0.00040914255,0.0011033678,0.001133958,0.00034319822,0.007314834,0.9157013,0.00024291924],"about_ca_topic_score_codex":0.778995,"about_ca_topic_score_gemma":0.8257914,"teacher_disagreement_score":0.94387317,"about_ca_system_score_codex":0.05612684,"about_ca_system_score_gemma":0.24808396,"threshold_uncertainty_score":0.4446131},"labels":[],"label_agreement":null},{"id":"W2246215802","doi":"10.1177/2055217315588223","title":"Cannabis-induced alterations in brain activation during a test of information processing speed in patients with MS","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cannabis; Effects of cannabis; Neuropsychology; Medicine; Anterior cingulate cortex; Audiology; Psychology; Neuroscience; Internal medicine; Psychiatry; Cognition; Cannabidiol","score_opus":0.12353141375967759,"score_gpt":0.3634025330788602,"score_spread":0.23987111931918265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2246215802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999814,0.00003115251,0.000016766538,0.000004199625,5.780968e-7,0.0000028347552,0.000023502795,0.0000010956171,0.00010579613],"genre_scores_gemma":[0.9998259,0.000020377884,0.000035779172,0.000004859959,0.0000018623011,0.000003589132,0.000035036854,7.985404e-7,0.000071766415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99992347,0.00001836794,0.000007489682,0.000019182402,0.000016204658,0.000015271347],"domain_scores_gemma":[0.99970955,0.00007640194,0.00012692128,0.0000144876985,0.000024478286,0.000048184356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011150062,0.0002078189,0.00020155804,0.00039954355,0.00020057015,0.0002630928,0.00009021541,0.00019376536,0.0016871048],"category_scores_gemma":[0.00078948337,0.000091131245,0.00010234239,0.00022231671,0.00021745171,0.00016083158,0.00016954537,0.00018435146,0.00013194545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0092922645,0.0005579199,0.861812,0.00010792978,0.000197824,0.001651858,0.0009683159,0.00028895683,0.10557975,0.000064928885,0.00011884045,0.019359434],"study_design_scores_gemma":[0.000026394986,0.0006065445,0.9971222,0.0000025490706,0.000015788666,0.0005976499,0.00011532265,0.00012630771,0.0013071146,0.000026449112,0.000050618313,0.0000030965628],"about_ca_topic_score_codex":0.0015056088,"about_ca_topic_score_gemma":0.002226515,"teacher_disagreement_score":0.0016871048,"about_ca_system_score_codex":0.00015995768,"about_ca_system_score_gemma":0.00011211633,"threshold_uncertainty_score":0.005643964},"labels":[],"label_agreement":null},{"id":"W2292463500","doi":"10.1177/2055217315618687","title":"A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; University of Ottawa","funders":"American Academy of Neurology","keywords":"Teriflunomide; Tolerability; Glatiramer acetate; Medicine; Placebo; Adverse effect; Multiple sclerosis; Internal medicine; Randomized controlled trial; Gastroenterology; Pharmacology; Immunology; Pathology; Fingolimod","score_opus":0.314488366734042,"score_gpt":0.41618649477243236,"score_spread":0.10169812803839035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2292463500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818764,0.0043887375,0.0007000265,0.000975007,0.0015588832,0.0069625154,0.0010092367,0.00020977858,0.0023194188],"genre_scores_gemma":[0.9784113,0.002949865,0.001869456,0.0016164558,0.0010272178,0.008599252,0.0011902925,0.000039313323,0.004296818],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987056,0.0008249896,0.00007131424,0.00018128044,0.00007235063,0.00014434574],"domain_scores_gemma":[0.99854493,0.0004944843,0.0002780009,0.00014151743,0.000085006024,0.00045614474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024311752,0.0018446689,0.0044258456,0.0005798534,0.000521736,0.0011819792,0.0010773189,0.0022466134,0.008871724],"category_scores_gemma":[0.0027266794,0.0009312194,0.0016914867,0.00045794627,0.0014573435,0.0010304115,0.00059051113,0.0032567543,0.0012771982],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9930426,0.0023109976,0.00011467603,0.000170858,0.00027656578,0.000019830262,0.000014390244,0.00007812004,0.00082854496,0.000034835237,0.00019304328,0.0029155605],"study_design_scores_gemma":[0.98103356,0.018233487,0.00026997452,0.00000769998,0.00011828015,0.0000090400345,0.0000046898945,0.000095991214,0.00007584874,0.000037430542,0.00011048805,0.000003570215],"about_ca_topic_score_codex":0.0008765474,"about_ca_topic_score_gemma":0.0015502777,"teacher_disagreement_score":0.008871724,"about_ca_system_score_codex":0.00061168213,"about_ca_system_score_gemma":0.0012541112,"threshold_uncertainty_score":0.029678881},"labels":[],"label_agreement":null},{"id":"W2336694595","doi":"10.1177/2055217316634111","title":"Delayed-release dimethyl fumarate and disability assessed by the Multiple Sclerosis Functional Composite: Integrated analysis of DEFINE and CONFIRM","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Marshall Space Flight Center; Biogen","keywords":"Dimethyl fumarate; Multiple sclerosis; Composite number; Psychology; Physical medicine and rehabilitation; Medicine; Chemistry; Materials science; Immunology; Composite material","score_opus":0.15989945607919162,"score_gpt":0.36311883009111656,"score_spread":0.20321937401192494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336694595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938968,0.0023903344,0.0008330946,0.000041573232,0.000010689655,0.000285304,0.0011374122,0.00003681024,0.0013681604],"genre_scores_gemma":[0.9963069,0.00041274895,0.0012867991,0.000031262523,0.000011231359,0.00017352334,0.0012151131,0.0000069612174,0.00055546925],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9992673,0.0003066252,0.000058979476,0.000069638714,0.00023690588,0.000060513026],"domain_scores_gemma":[0.998718,0.0002178712,0.0006746146,0.00006546111,0.00018626415,0.00013778191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021991837,0.00057189754,0.0010701999,0.00072734826,0.00018107264,0.00033480642,0.0003070769,0.00023980436,0.0007539949],"category_scores_gemma":[0.0014594856,0.00014331166,0.00077468716,0.00053622754,0.00016745001,0.00030237375,0.0003431171,0.00040887544,0.0001224447],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17559333,0.0035939415,0.6325959,0.0009836525,0.006105541,0.00016191317,0.00028833354,0.0027240515,0.033150185,0.00029592484,0.0013355034,0.1431718],"study_design_scores_gemma":[0.0033311597,0.02980914,0.95178795,0.00004399568,0.001682055,0.00041911265,0.000053883767,0.0015444445,0.009302213,0.000099927114,0.0018861357,0.00003995718],"about_ca_topic_score_codex":0.0013914217,"about_ca_topic_score_gemma":0.0036759248,"teacher_disagreement_score":0.0021991837,"about_ca_system_score_codex":0.00036636944,"about_ca_system_score_gemma":0.00034768754,"threshold_uncertainty_score":0.011630535},"labels":[],"label_agreement":null},{"id":"W2403913513","doi":"10.1177/2055217316649981","title":"Erythrocytes in multiple sclerosis – forgotten contributors to the pathophysiology?","year":2016,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Trish Multiple Sclerosis Research Foundation; Hunter Medical Research Institute; Multiple Sclerosis Australia; Canadian Institutes of Health Research; Bond University","keywords":"Multiple sclerosis; Disease; Autoimmunity; Pathological; Myelin; Genetic predisposition; Immune system; Immunology; Pathophysiology; Experimental autoimmune encephalomyelitis; Autoimmune disease; Medicine; Neuroscience; Central nervous system; Pathology; Biology","score_opus":0.20962813595600904,"score_gpt":0.3783915462416644,"score_spread":0.16876341028565534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403913513","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051411378,0.9991215,0.000033286502,0.00035829504,0.00019310799,8.2854626e-7,0.0000027883257,0.0000019398972,0.0002368198],"genre_scores_gemma":[0.00059564516,0.99848074,0.00007565372,0.00021525609,0.00029234178,0.0000018469125,0.0000073789893,7.900182e-7,0.00033036337],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999801,0.000053488333,0.00003498029,0.000028027793,0.00006251649,0.00002002632],"domain_scores_gemma":[0.99971527,0.00012557318,0.000039723614,0.000009841009,0.00007733359,0.000032295382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006746642,0.00064371503,0.001259648,0.0017312281,0.0004083961,0.0013779845,0.00085821265,0.0018719925,0.0022775799],"category_scores_gemma":[0.0008096409,0.0002486714,0.0003270167,0.0016727366,0.00093029655,0.0022028312,0.0009827081,0.0021183658,0.0017940516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015152489,0.00006632232,0.0002990649,0.016220136,0.000081417355,0.00053328014,0.0002949834,0.00021878032,0.0020599123,0.011487602,0.043104544,0.92548245],"study_design_scores_gemma":[0.000015281134,0.00008796999,0.00061710225,0.005382413,0.00005691845,0.0029089975,0.0001910826,0.000048231395,0.00036953835,0.005080874,0.9852239,0.000017737957],"about_ca_topic_score_codex":0.0011441387,"about_ca_topic_score_gemma":0.00152052,"teacher_disagreement_score":0.0022775799,"about_ca_system_score_codex":0.0005954624,"about_ca_system_score_gemma":0.0010234558,"threshold_uncertainty_score":0.0076192617},"labels":[],"label_agreement":null},{"id":"W2415546685","doi":"10.1177/2055217316653150","title":"Distractibility in multiple sclerosis: The role of depression","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Health Sciences Centre; University of Toronto; Carleton University; Sunnybrook Health Science Centre","funders":"","keywords":"Depression (economics); Anxiety; Psychology; Hospital Anxiety and Depression Scale; Multiple sclerosis; Cognition; Clinical psychology; Developmental psychology; Psychiatry","score_opus":0.18417794540964375,"score_gpt":0.379125427741175,"score_spread":0.19494748233153128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415546685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99888843,0.00064524816,0.000048347963,0.000033364948,0.000003147435,0.000005057725,0.00002012604,0.0000012092047,0.0003550598],"genre_scores_gemma":[0.9996842,0.00015403582,0.00005729304,0.000016510217,0.0000052204555,0.0000027387748,0.000016402699,3.6202456e-7,0.00006331597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99944633,0.00024766225,0.000057038415,0.000056250432,0.00015122983,0.000041496725],"domain_scores_gemma":[0.99639124,0.0015465874,0.0013949366,0.00011071555,0.00021231685,0.0003441956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000688157,0.00026535653,0.0002973078,0.00048706628,0.00026055236,0.0005875167,0.00016968996,0.0002976047,0.0008420388],"category_scores_gemma":[0.0047562807,0.00014604865,0.00028977878,0.00031067003,0.00031923826,0.00023994799,0.00046539266,0.00038039658,0.0001227881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007544185,0.00023119531,0.98145735,0.000056621844,0.00012061151,0.00015623687,0.0003604895,0.000059688806,0.0014467945,0.000025445932,0.00004340081,0.015287813],"study_design_scores_gemma":[0.000006763221,0.00021490693,0.9991492,0.000008467339,0.00003777009,0.00023283143,0.00009811964,0.000092792434,0.00009511823,0.000024597119,0.00003673764,0.000002768237],"about_ca_topic_score_codex":0.0017754145,"about_ca_topic_score_gemma":0.0031394986,"teacher_disagreement_score":0.0017754145,"about_ca_system_score_codex":0.00024623872,"about_ca_system_score_gemma":0.00018944718,"threshold_uncertainty_score":0.0036393404},"labels":[],"label_agreement":null},{"id":"W2466340424","doi":"10.1177/2055217316657116","title":"Cognitive evolution in natalizumab-treated multiple sclerosis patients","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Clinique Neuro-Outaouais","funders":"","keywords":"Natalizumab; Multiple sclerosis; Medicine; Cognition; Oncology; Psychiatry","score_opus":0.16508463180883598,"score_gpt":0.37209468421428116,"score_spread":0.20701005240544518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2466340424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99959105,0.00016303088,0.00001543792,0.000017002485,0.0000026104235,0.000004638156,0.0000597937,0.0000016413912,0.00014473782],"genre_scores_gemma":[0.99970394,0.000050672475,0.00002012166,0.000017750835,0.000005991865,0.000005097343,0.00013856207,7.2308256e-7,0.000057131794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995685,0.00012770733,0.000054543616,0.00007912803,0.00009068268,0.00007935641],"domain_scores_gemma":[0.9983935,0.0002956283,0.00076482224,0.00007735304,0.0001479702,0.00032073015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007708949,0.00034568613,0.0006078928,0.000701867,0.00077411596,0.0008063568,0.000331218,0.0005900965,0.0007929338],"category_scores_gemma":[0.0027067286,0.00021363463,0.000573758,0.0008347883,0.00026298172,0.00049978815,0.00035528213,0.0009119996,0.00022474078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018679932,0.00026560045,0.99379784,0.000017282762,0.000110695095,0.00032951747,0.0002308642,0.00006745322,0.00043455136,0.000009797287,0.000071747585,0.0027965985],"study_design_scores_gemma":[0.000050605544,0.00077189517,0.9980427,0.000005205793,0.00006294251,0.0005651115,0.000116335425,0.0001763735,0.00007839532,0.000020905129,0.00010209789,0.0000074288805],"about_ca_topic_score_codex":0.0035794794,"about_ca_topic_score_gemma":0.0033625895,"teacher_disagreement_score":0.0035794794,"about_ca_system_score_codex":0.000510989,"about_ca_system_score_gemma":0.00037383163,"threshold_uncertainty_score":0.0071172714},"labels":[],"label_agreement":null},{"id":"W2512072495","doi":"10.1177/2055217316666406","title":"Prognostic factors for long-term outcomes in relapsing–remitting multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Javna Agencija za Raziskovalno Dejavnost RS; Neuroscience Research Australia; Teva Pharmaceutical Industries","keywords":"Medicine; Proportional hazards model; Internal medicine; Stepwise regression; Univariate; Univariate analysis; Multiple sclerosis; Multivariate analysis; Relapsing remitting; Post-hoc analysis; Multivariate statistics; Disease","score_opus":0.2925809029787263,"score_gpt":0.4110410526671394,"score_spread":0.11846014968841312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512072495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803776,0.0013086036,0.00017580786,0.00008611715,0.000009844097,0.0000043193554,0.00019230323,0.000005063186,0.00018013587],"genre_scores_gemma":[0.99943453,0.00015160335,0.00010633374,0.000009597501,0.0000188635,0.0000052292903,0.00016667956,0.0000012188525,0.000106015905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947995,0.00028649875,0.000049720064,0.00006271505,0.000055703746,0.000065434564],"domain_scores_gemma":[0.99453545,0.0023608096,0.0022086657,0.00021036729,0.00023035443,0.00045437407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020760135,0.000400838,0.0003283306,0.00054445426,0.00020390294,0.00046487772,0.00032835128,0.0004429912,0.0016160867],"category_scores_gemma":[0.0075003197,0.00011821293,0.0005188242,0.00060700445,0.00023546607,0.00040035832,0.00035471862,0.000634941,0.00017303984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001101146,0.000055338845,0.99500567,0.000023874232,0.00014795523,0.00007798991,0.000023880313,0.00019911205,0.00012188132,0.000017092974,0.0000630146,0.003163202],"study_design_scores_gemma":[0.00003814271,0.00048267533,0.99806243,0.000021461434,0.00015358864,0.00018078812,0.000069683876,0.00064513437,0.00011001502,0.00009899308,0.00013253422,0.000004470113],"about_ca_topic_score_codex":0.0007796008,"about_ca_topic_score_gemma":0.0010663118,"teacher_disagreement_score":0.0020760135,"about_ca_system_score_codex":0.00010723948,"about_ca_system_score_gemma":0.00027343683,"threshold_uncertainty_score":0.010979176},"labels":[],"label_agreement":null},{"id":"W2512341706","doi":"10.1177/2055217316666093","title":"Multiple sclerosis in First Nations Canadians: A pilot comparison study","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Manitoba","funders":"Ministry of Economy, Trade and Industry; Multiple Sclerosis Society","keywords":"Ethnic group; Multiple sclerosis; Observational study; Medicine; Odds; Odds ratio; Statistical significance; Internal medicine; Demography; Clinical psychology; Psychiatry; Logistic regression","score_opus":0.28255504074704574,"score_gpt":0.40361573542825513,"score_spread":0.12106069468120939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512341706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973973,0.00019203305,0.000051711224,0.000043186163,0.0000073527076,0.00028149073,0.0011827075,0.0000028361515,0.000841344],"genre_scores_gemma":[0.99743843,0.00030648516,0.00032050037,0.0001005431,0.000012151597,0.00019865487,0.0011180087,0.0000029334012,0.0005022073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932754,0.00007602923,0.0000402645,0.00013483144,0.00016902057,0.00025235923],"domain_scores_gemma":[0.9988331,0.00008776286,0.00020681146,0.0000723783,0.00043142238,0.0003685208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010990393,0.0010115172,0.00075594604,0.0014570672,0.0050647203,0.0007412551,0.0009287803,0.0006872261,0.0031922052],"category_scores_gemma":[0.0015947903,0.0004375765,0.0008747448,0.002661867,0.0007560278,0.00047313553,0.000999109,0.0005909627,0.0003784425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020931256,0.001134004,0.9799068,0.00032460125,0.00030784457,0.0007946374,0.0052047237,0.00007672532,0.0011306118,0.00024982114,0.0011736825,0.007603327],"study_design_scores_gemma":[0.0002966477,0.0009350704,0.99321544,0.00003885594,0.00013494231,0.00030857194,0.0038651286,0.000100823956,0.00008589628,0.000035843146,0.0009603882,0.00002231696],"about_ca_topic_score_codex":0.9248235,"about_ca_topic_score_gemma":0.93674797,"teacher_disagreement_score":0.07517648,"about_ca_system_score_codex":0.008505382,"about_ca_system_score_gemma":0.009247007,"threshold_uncertainty_score":0.15123838},"labels":[],"label_agreement":null},{"id":"W2550262071","doi":"10.1177/2055217316680638","title":"Coping strategies in relation to negative work events and accommodations in employed multiple sclerosis patients","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; ZonMw; Mallinckrodt Pharmaceuticals; Biogen","keywords":"Coping (psychology); Presenteeism; Psychology; Absenteeism; Demographics; Clinical psychology; Cognition; Multiple sclerosis; Job loss; Sick leave; Medicine; Physical therapy; Social psychology; Psychiatry; Unemployment","score_opus":0.19331978171828573,"score_gpt":0.38829531481398183,"score_spread":0.1949755330956961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550262071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99973327,0.00009802665,0.0000117584705,0.000027358901,0.0000015068966,0.0000027045076,0.000022452083,4.709146e-7,0.00010234723],"genre_scores_gemma":[0.9998553,0.000048700007,0.000017599346,0.00000942176,0.0000020817138,0.0000036031236,0.000026980784,2.2285772e-7,0.000036059475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997509,0.00008239802,0.000036214442,0.000025765252,0.00004875324,0.00005595838],"domain_scores_gemma":[0.9981844,0.00036628966,0.0010566934,0.00003408149,0.000087994056,0.0002706154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045695555,0.00023311297,0.0002280794,0.00056738546,0.00031699613,0.00050368597,0.00015908566,0.0002679627,0.0014986728],"category_scores_gemma":[0.0031216475,0.0001111447,0.0002921099,0.00047620825,0.00023880819,0.00020032094,0.00038174487,0.00038341293,0.00012704328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012720664,0.00007375712,0.9969675,0.000014710556,0.000034867953,0.00020707525,0.00046465205,0.00003918309,0.00016822836,0.000009335317,0.000039258575,0.0018542617],"study_design_scores_gemma":[0.000010725558,0.00019816915,0.99809414,0.000011889355,0.000016452168,0.00056943,0.0008352536,0.00011727437,0.000041255804,0.000022591184,0.000078363926,0.0000043869663],"about_ca_topic_score_codex":0.0008871348,"about_ca_topic_score_gemma":0.0011173163,"teacher_disagreement_score":0.0014986728,"about_ca_system_score_codex":0.00016493801,"about_ca_system_score_gemma":0.00017353025,"threshold_uncertainty_score":0.0050135255},"labels":[],"label_agreement":null},{"id":"W2553060585","doi":"10.1177/2055217316676644","title":"Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis","year":2016,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Multiple sclerosis; Internal medicine; Placebo; Post-hoc analysis; Gastroenterology; Psychiatry; Pathology","score_opus":0.09819724325926502,"score_gpt":0.3219276521096802,"score_spread":0.2237304088504152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553060585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961533,0.0028343748,0.00010469664,0.00014361949,0.000022469763,0.0001220978,0.00009371084,0.000017148206,0.00050860166],"genre_scores_gemma":[0.99835867,0.0007473228,0.00030378962,0.00010660766,0.000042991476,0.00010756015,0.00012719708,0.0000023372709,0.00020364064],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99913424,0.00052889134,0.00006394323,0.00008447142,0.00011882494,0.00006959359],"domain_scores_gemma":[0.9991227,0.00028277317,0.00031950764,0.00006866495,0.000057674195,0.00014868748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025004786,0.00038570602,0.0010160006,0.00024670776,0.00017161376,0.00025606502,0.00027021702,0.00036970823,0.00162509],"category_scores_gemma":[0.0023295502,0.00014528581,0.00084334967,0.00028578783,0.00027227582,0.00028623393,0.00026300576,0.0007474757,0.00020136709],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4997046,0.017880717,0.115415275,0.0019096616,0.0036970715,0.00020523064,0.00035413582,0.0011494333,0.012637856,0.000116480325,0.0016262314,0.3453034],"study_design_scores_gemma":[0.078898855,0.2733487,0.63612604,0.00027220693,0.0022633055,0.00057920394,0.00016055301,0.0015126832,0.004547475,0.0002793959,0.0019727359,0.000038879996],"about_ca_topic_score_codex":0.0003621111,"about_ca_topic_score_gemma":0.0006323656,"teacher_disagreement_score":0.0025004786,"about_ca_system_score_codex":0.00026047957,"about_ca_system_score_gemma":0.00043472517,"threshold_uncertainty_score":0.013223946},"labels":[],"label_agreement":null},{"id":"W2586478668","doi":"10.1177/2055217317690561","title":"Noninvasive tongue stimulation combined with intensive cognitive and physical rehabilitation induces neuroplastic changes in patients with multiple sclerosis: A multimodal neuroimaging study","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University; McGill University; Montreal Neurological Institute and Hospital","funders":"Concordia University; McGill University","keywords":"Working memory; Physical medicine and rehabilitation; Premotor cortex; Neuroplasticity; Psychology; Neuromodulation; Medicine; Neuroimaging; Multiple sclerosis; Transcranial direct-current stimulation; Functional magnetic resonance imaging; Dorsolateral prefrontal cortex; Rehabilitation; Cognition; Neuroscience; Stimulation; Prefrontal cortex","score_opus":0.1101354382697149,"score_gpt":0.3611037731074665,"score_spread":0.2509683348377516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586478668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996517,0.00011514984,0.000048150654,0.000010263673,0.0000014853808,0.000012443752,0.000005697078,0.0000012578872,0.0001540026],"genre_scores_gemma":[0.99963355,0.00010189353,0.00008520313,0.000019147785,0.00001387469,0.000017955765,0.000019900901,6.8925476e-7,0.000107821135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9999287,0.000020766445,0.000006170573,0.000016516744,0.000013918763,0.000013802283],"domain_scores_gemma":[0.9998903,0.00003122741,0.000032776865,0.000008120654,0.000010817768,0.000026704796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001970914,0.00030767414,0.0003496504,0.00020373931,0.00020367657,0.00016730717,0.00011446253,0.00028313356,0.0011568393],"category_scores_gemma":[0.00041362792,0.000110426954,0.00024306246,0.00012396762,0.0002690217,0.00018662518,0.00017736472,0.00019599119,0.00015002812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04416124,0.011303383,0.45441675,0.0009072625,0.0008626731,0.010917794,0.002678867,0.0005111164,0.33574393,0.000109666005,0.00047626888,0.13791113],"study_design_scores_gemma":[0.0012810562,0.03007064,0.9555145,0.000027872551,0.00032968557,0.005159128,0.00051056256,0.00059881265,0.005818925,0.00007416925,0.00059841364,0.000016257527],"about_ca_topic_score_codex":0.0003739113,"about_ca_topic_score_gemma":0.00053497555,"teacher_disagreement_score":0.0011568393,"about_ca_system_score_codex":0.00012420748,"about_ca_system_score_gemma":0.00013740822,"threshold_uncertainty_score":0.0038700104},"labels":[],"label_agreement":null},{"id":"W2623186536","doi":"10.1177/2055217317713027","title":"Cannabis and cognitive functioning in multiple sclerosis: The role of gender","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society","keywords":"Cannabis; Psychology; Cognition; Recall; California Verbal Learning Test; Effects of cannabis; Effects of sleep deprivation on cognitive performance; Verbal memory; Verbal learning; Clinical psychology; Psychiatry; Developmental psychology; Audiology; Medicine; Cannabidiol","score_opus":0.16839586832298536,"score_gpt":0.3693324806192172,"score_spread":0.20093661229623183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623186536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99641883,0.0024508343,0.00006339937,0.00010060865,0.000009510082,0.0000053604676,0.00016603786,0.0000020970122,0.00078319694],"genre_scores_gemma":[0.99948114,0.00029547067,0.000037581685,0.000014072878,0.000007024555,0.0000017238201,0.000038811726,0.0000010945298,0.00012302656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974257,0.00007577222,0.000025815556,0.000045228797,0.00006322794,0.000047332065],"domain_scores_gemma":[0.99891233,0.00040198423,0.00043321465,0.000050681865,0.00006852014,0.00013328478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005039659,0.00018642492,0.00032521685,0.0007460265,0.00041942354,0.00056409725,0.00021947909,0.0002751259,0.0022354512],"category_scores_gemma":[0.0021643827,0.00009931454,0.00034558002,0.00070923165,0.00037992926,0.0003853668,0.00039579303,0.00024619364,0.00016443896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040892145,0.000042248925,0.99200433,0.000036207446,0.00007228866,0.00023742153,0.00029605775,0.0000352575,0.0004920971,0.00008484802,0.00006243843,0.006227846],"study_design_scores_gemma":[0.0000032834791,0.00009731314,0.9986706,0.000017854052,0.00003247785,0.0005282634,0.00020310139,0.000092971866,0.00007166134,0.00010101167,0.00017811375,0.0000034494813],"about_ca_topic_score_codex":0.0063680164,"about_ca_topic_score_gemma":0.006770931,"teacher_disagreement_score":0.0063680164,"about_ca_system_score_codex":0.00027841452,"about_ca_system_score_gemma":0.00031400868,"threshold_uncertainty_score":0.012661874},"labels":[],"label_agreement":null},{"id":"W2752881099","doi":"10.1177/2055217317728301","title":"Which symptoms contribute the most to patients’ perception of health in multiple sclerosis?","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Multiple sclerosis; Medicine; Disease; Physical therapy; Perception; Clinical psychology; Psychology; Psychiatry; Internal medicine","score_opus":0.1878634042181931,"score_gpt":0.40003885592101746,"score_spread":0.21217545170282437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752881099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728763,0.0011472442,0.00011439858,0.0007101831,0.000013371187,0.000006689015,0.00012757143,0.0000037530278,0.000589293],"genre_scores_gemma":[0.9995074,0.00023638207,0.00006744879,0.0000720124,0.000018463794,0.0000029650366,0.000055236786,9.3783405e-7,0.00003906165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994843,0.00022246668,0.00006384764,0.0000614421,0.0000974125,0.000070384485],"domain_scores_gemma":[0.99746525,0.00076123385,0.0011988161,0.000044293363,0.00019482315,0.00033564813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074319105,0.00019451838,0.00035716707,0.0005096187,0.00024724324,0.0006754916,0.00018196189,0.0004013867,0.002181074],"category_scores_gemma":[0.004787493,0.00011334208,0.00041991423,0.00057304994,0.00037567184,0.0005963743,0.00039603628,0.00048989773,0.00014742881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011301302,0.000025178142,0.9868996,0.000074556905,0.000075227,0.00007882894,0.00060034153,0.000057471476,0.00023774014,0.0000232171,0.00028394052,0.011530935],"study_design_scores_gemma":[0.0000063205503,0.00006920341,0.99816614,0.000028624427,0.000033361302,0.0002776242,0.0009846805,0.00013988232,0.000040913932,0.00008260807,0.00016460568,0.000006155363],"about_ca_topic_score_codex":0.0014971351,"about_ca_topic_score_gemma":0.002615374,"teacher_disagreement_score":0.002181074,"about_ca_system_score_codex":0.00029042765,"about_ca_system_score_gemma":0.0002797401,"threshold_uncertainty_score":0.007296443},"labels":[],"label_agreement":null},{"id":"W2760399652","doi":"10.1177/2055217317730096","title":"A comparison of multiple sclerosis disease activity after discontinuation of fingolimod and placebo","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Novartis Pharma; Novartis; Teva Pharmaceutical Industries; IC Design Education Center; Bayer HealthCare; Biogen","keywords":"Fingolimod; Discontinuation; Placebo; Medicine; Multiple sclerosis; Internal medicine; Clinical trial; Pathology; Psychiatry; Alternative medicine","score_opus":0.2742009206191111,"score_gpt":0.4397625722494697,"score_spread":0.16556165163035858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2760399652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966246,0.0018469081,0.0003855516,0.000039217983,0.000017981723,0.000065746135,0.00035160323,0.000012771837,0.0006557046],"genre_scores_gemma":[0.9991229,0.00018185584,0.00013697149,0.000018868483,0.00002530991,0.000052626972,0.0003630842,0.0000027160706,0.000095622876],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9949045,0.0030581537,0.0005601161,0.0004343324,0.00082807825,0.00021482924],"domain_scores_gemma":[0.9763123,0.014279636,0.007286553,0.00089506333,0.00060369173,0.0006227531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008760062,0.00034152565,0.0010317105,0.0007118569,0.0001393909,0.00054794335,0.00029387532,0.0005265112,0.0012093167],"category_scores_gemma":[0.013018505,0.00011152359,0.0012597129,0.00038732673,0.0003541901,0.0005388157,0.0004311707,0.0005832993,0.00013332069],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40610352,0.0009550315,0.5128614,0.0010129598,0.0052979593,0.0003196152,0.0003321847,0.0019012804,0.0068846,0.00027611162,0.00049281213,0.06356261],"study_design_scores_gemma":[0.0037165296,0.07197508,0.9158481,0.000078179,0.0013239455,0.00068963616,0.0001214357,0.0019781145,0.0025297443,0.00039897763,0.001307954,0.000032349253],"about_ca_topic_score_codex":0.00015471896,"about_ca_topic_score_gemma":0.00013617508,"teacher_disagreement_score":0.008760062,"about_ca_system_score_codex":0.0003293159,"about_ca_system_score_gemma":0.00028310198,"threshold_uncertainty_score":0.046328187},"labels":[],"label_agreement":null},{"id":"W2761038804","doi":"10.1177/2055217317732802","title":"The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"EMD Serono; Merck KGaA","keywords":"Cladribine; Medicine; Oracle; Internal medicine; Computer science; Programming language","score_opus":0.25753686679645316,"score_gpt":0.43096976525358616,"score_spread":0.173432898457133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761038804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986743,0.00093223737,0.00003701157,0.000018003693,0.000010803922,0.000037527323,0.00008360157,0.0000031055706,0.00020345826],"genre_scores_gemma":[0.9993284,0.0002603593,0.00008162956,0.000027149365,0.000022275814,0.000016279098,0.00020873363,0.0000010015004,0.000054344342],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.999271,0.00039044014,0.00008490889,0.00010254908,0.00009748267,0.000053607528],"domain_scores_gemma":[0.9980222,0.0005697477,0.0005711028,0.00019432185,0.00012452334,0.0005180611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001613562,0.00048918475,0.0013133673,0.00022950144,0.00017645617,0.0004420516,0.00026698396,0.0003890012,0.00061324565],"category_scores_gemma":[0.0019517925,0.00021115226,0.0006776665,0.00020267926,0.0003681805,0.00026222883,0.00028023048,0.00066951284,0.00015473533],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.587219,0.005519419,0.31854567,0.0006937051,0.0021705853,0.00042660098,0.00041222989,0.0012470378,0.023490746,0.00010331992,0.0006044156,0.059567355],"study_design_scores_gemma":[0.05413303,0.1979526,0.73618615,0.000103600476,0.0019488934,0.0012373868,0.0002536016,0.0025702904,0.0036896744,0.000106450156,0.0017387226,0.0000795786],"about_ca_topic_score_codex":0.00039475452,"about_ca_topic_score_gemma":0.0006801433,"teacher_disagreement_score":0.001613562,"about_ca_system_score_codex":0.00025003986,"about_ca_system_score_gemma":0.00029622586,"threshold_uncertainty_score":0.008533418},"labels":[],"label_agreement":null},{"id":"W2769634427","doi":"10.1177/2055217317743097","title":"A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Acorda Therapeutics","keywords":"Tolerability; Placebo; Medicine; Pharmacodynamics; Pharmacokinetics; Multiple sclerosis; Adverse effect; Cohort; Internal medicine; Dosing; Biomarker; Pharmacology; Gastroenterology; Immunology; Pathology; Chemistry","score_opus":0.24974457371290776,"score_gpt":0.42491054057191163,"score_spread":0.17516596685900387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769634427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99647695,0.00084389944,0.0002403563,0.00010291452,0.00008974823,0.0015864251,0.00021630201,0.00003771426,0.0004056953],"genre_scores_gemma":[0.9936399,0.0006443214,0.0009847197,0.00040667216,0.00023756929,0.0023406618,0.00026686088,0.0000090325575,0.001470204],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993692,0.00027125305,0.000057314766,0.00013295133,0.00006603889,0.00010327802],"domain_scores_gemma":[0.9992508,0.00014571006,0.0001709178,0.00006810672,0.000085978536,0.00027843364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016831261,0.0014162422,0.0023050187,0.00032954582,0.00061045354,0.0005177608,0.0005661039,0.0013914945,0.0032449486],"category_scores_gemma":[0.0012791606,0.00069636805,0.0008008525,0.00020534554,0.0007496861,0.0006182168,0.00030652175,0.0014351357,0.00072862895],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92638785,0.034333706,0.003483196,0.00047724592,0.00051298714,0.00007136647,0.00017927674,0.00016189602,0.014433593,0.000027127004,0.00036821843,0.019563416],"study_design_scores_gemma":[0.58897614,0.39334354,0.014635182,0.000020329093,0.00038414926,0.00005928486,0.00003894721,0.00019305556,0.0016274904,0.000055445864,0.0006506535,0.000015836029],"about_ca_topic_score_codex":0.00051477697,"about_ca_topic_score_gemma":0.001002755,"teacher_disagreement_score":0.0032449486,"about_ca_system_score_codex":0.0003046028,"about_ca_system_score_gemma":0.000895439,"threshold_uncertainty_score":0.010855377},"labels":[],"label_agreement":null},{"id":"W2771252242","doi":"10.1177/2055217317745340","title":"Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trials","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Merck KGaA","keywords":"Multiple sclerosis; Placebo; Internal medicine; Medicine; Quartile; Gastroenterology; Lesion; Odds ratio; Pathology; Immunology; Confidence interval","score_opus":0.1445675270265466,"score_gpt":0.3956341391109991,"score_spread":0.25106661208445247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2771252242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706673,0.02658568,0.00043792097,0.00036723365,0.0001346682,0.0007014079,0.00040068958,0.000029094863,0.00067597383],"genre_scores_gemma":[0.9911509,0.0066756695,0.00056436675,0.00019375295,0.00011966373,0.00050376443,0.00035169802,0.000005636841,0.0004344782],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99710613,0.0021615021,0.00022703952,0.00019478626,0.00018690174,0.00012373885],"domain_scores_gemma":[0.99655765,0.0016469046,0.0011374473,0.00019454755,0.000118122334,0.0003452503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061349776,0.0009084061,0.0023392064,0.00051453145,0.00018914124,0.0007765375,0.0005864766,0.000855376,0.0014429099],"category_scores_gemma":[0.004645791,0.000401424,0.0034287125,0.00058518845,0.0008077987,0.000617401,0.00047366243,0.0014281635,0.00014381445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9281947,0.0017418741,0.0109516205,0.003177404,0.014747187,0.00009400641,0.00008953479,0.0010752872,0.0025411036,0.00017008244,0.00037588098,0.036841363],"study_design_scores_gemma":[0.7596041,0.16479807,0.056336645,0.00041447012,0.013199013,0.00031854867,0.00012514117,0.0015690384,0.00084627006,0.0006528871,0.0020847546,0.000051011015],"about_ca_topic_score_codex":0.00041763214,"about_ca_topic_score_gemma":0.00079484173,"teacher_disagreement_score":0.0061349776,"about_ca_system_score_codex":0.0005520757,"about_ca_system_score_gemma":0.00078427914,"threshold_uncertainty_score":0.032445192},"labels":[],"label_agreement":null},{"id":"W2779004527","doi":"10.1177/2055217317747625","title":"Environmental temperature and exercise modality independently impact central and muscle fatigue among people with multiple sclerosis","year":2017,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Agencia Estatal de Investigación","keywords":"Multiple sclerosis; Modality (human–computer interaction); Physical medicine and rehabilitation; Muscle fatigue; Psychology; Physical therapy; Medicine; Psychiatry; Computer science; Electromyography; Artificial intelligence","score_opus":0.10784482978458117,"score_gpt":0.35341353616226173,"score_spread":0.24556870637768058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2779004527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99942744,0.00025635626,0.000028008933,0.000018640756,0.0000017138647,0.000005192528,0.000050424205,0.0000018801339,0.0002104253],"genre_scores_gemma":[0.9997733,0.00007310368,0.000036033627,0.000010376407,0.0000032797682,0.000004293715,0.00003149555,5.612708e-7,0.00006743097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980825,0.000052970434,0.000021143775,0.000037699327,0.00004197433,0.00003808181],"domain_scores_gemma":[0.99947363,0.00013686494,0.00022164857,0.00002461529,0.00006514324,0.00007816027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022783205,0.00022094884,0.00034807177,0.000249823,0.00029522722,0.00028074416,0.00011302542,0.0002868259,0.0017766469],"category_scores_gemma":[0.0011924579,0.00010404989,0.00030468532,0.00029959407,0.00017310849,0.00020979586,0.0003336097,0.00023361247,0.00017190675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035341326,0.0001157526,0.991433,0.000059005906,0.00008836119,0.00006529926,0.00019229492,0.00005823116,0.0012568716,0.0000047595126,0.000056224577,0.006316784],"study_design_scores_gemma":[0.0000038951207,0.00016973606,0.99950325,0.0000045984107,0.00002606303,0.00007701246,0.000093802795,0.000033895252,0.00004538767,0.0000082420165,0.000032976524,0.0000012218252],"about_ca_topic_score_codex":0.0017346605,"about_ca_topic_score_gemma":0.004061177,"teacher_disagreement_score":0.0017766469,"about_ca_system_score_codex":0.00011461095,"about_ca_system_score_gemma":0.00010566166,"threshold_uncertainty_score":0.0059434175},"labels":[],"label_agreement":null},{"id":"W2791060017","doi":"10.1177/2055217318761168","title":"Prolonged-Release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients: A Pilot, Double-Blind, Randomized, Placebo-Controlled Study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Clinique Neuro-Outaouais","funders":"Sanofi Genzyme; Biogen; Teva Pharmaceutical Industries; American Academy of Neurology","keywords":"Placebo; Medicine; Randomized controlled trial; Statistical significance; Physical therapy; Rehabilitation; Clinical trial; Surgery; Internal medicine","score_opus":0.2179546519039415,"score_gpt":0.41506609884793993,"score_spread":0.19711144694399843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791060017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816922,0.004128451,0.0008576261,0.00029755986,0.0005940067,0.010722249,0.00070759415,0.00011848695,0.0008817837],"genre_scores_gemma":[0.97231954,0.0037507887,0.0038521881,0.000774465,0.0013567237,0.015019705,0.0006989832,0.000025301482,0.0022023364],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986551,0.0007080892,0.00014360814,0.00020408593,0.00013515718,0.00015400791],"domain_scores_gemma":[0.99791914,0.0006582931,0.0004189101,0.00020358205,0.00022345259,0.000576727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031098567,0.0014230574,0.005650987,0.0007075789,0.00072446425,0.0008423561,0.0013102107,0.0024887908,0.006869755],"category_scores_gemma":[0.0026832256,0.00089943956,0.0015066176,0.0008141238,0.0020158994,0.0013556501,0.0005190666,0.0022110625,0.00097330956],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9664454,0.019887924,0.0003323621,0.00068427686,0.0003440458,0.000041163366,0.000047009053,0.000059303744,0.0040657655,0.000030758572,0.00018782384,0.007874239],"study_design_scores_gemma":[0.8148547,0.18285431,0.0012387234,0.00002172393,0.00023634452,0.000025348218,0.000015137108,0.00010609125,0.00036653684,0.000026725018,0.00024604058,0.000008406442],"about_ca_topic_score_codex":0.0006199639,"about_ca_topic_score_gemma":0.001233325,"teacher_disagreement_score":0.006869755,"about_ca_system_score_codex":0.0004758736,"about_ca_system_score_gemma":0.0014459258,"threshold_uncertainty_score":0.022981644},"labels":[],"label_agreement":null},{"id":"W2791535469","doi":"10.1177/2055217318760642","title":"No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; NeuroRx Research (Canada); Research Canada","funders":"Roche","keywords":"Ocrelizumab; Medicine; Multiple sclerosis; Internal medicine; Interferon beta-1a; Gastroenterology; Interferon beta; Immunology","score_opus":0.12229452787253223,"score_gpt":0.358712952255066,"score_spread":0.23641842438253377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791535469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962471,0.0028743015,0.0001963895,0.000020428533,0.000014219978,0.000033799242,0.00022300522,0.000004999881,0.00038575195],"genre_scores_gemma":[0.998982,0.00027186648,0.00014045082,0.000028396707,0.000018186583,0.000039899885,0.000374878,0.000002577274,0.00014166257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757034,0.0012852512,0.00034455658,0.00040876155,0.00026333905,0.00012779453],"domain_scores_gemma":[0.9951761,0.0020709224,0.0017187531,0.00043347155,0.00021563185,0.000385113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054947753,0.000472186,0.0016092507,0.0005373281,0.00016743451,0.0007257468,0.00029880163,0.00041448558,0.0004519062],"category_scores_gemma":[0.003919486,0.0002593691,0.0020709008,0.00044165543,0.00026417512,0.00048495238,0.0005492174,0.0006242135,0.00008681051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17864558,0.00046722457,0.77959865,0.00046378848,0.0074446094,0.00016431732,0.00021690692,0.00094411575,0.0059728986,0.00006763329,0.00021220848,0.025802096],"study_design_scores_gemma":[0.0026437924,0.013138644,0.97559154,0.000045395784,0.0047621042,0.00020160276,0.00007525188,0.0011862636,0.0011844028,0.0001166597,0.001024943,0.000029384],"about_ca_topic_score_codex":0.0003361076,"about_ca_topic_score_gemma":0.00066039176,"teacher_disagreement_score":0.0054947753,"about_ca_system_score_codex":0.0003074161,"about_ca_system_score_gemma":0.00024962303,"threshold_uncertainty_score":0.02905947},"labels":[],"label_agreement":null},{"id":"W2792025795","doi":"10.1177/2055217318754368","title":"National estimates of self-reported sitting time in adults with multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Multiple Sclerosis Society","keywords":"Sitting; Medicine; Underweight; Physical therapy; Demography; Population; Multiple sclerosis; Pediatrics; Internal medicine; Body mass index; Psychiatry; Environmental health","score_opus":0.1379962288639107,"score_gpt":0.3734471099918637,"score_spread":0.235450881127953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2792025795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984414,0.0010661052,0.00039386502,0.00013146456,0.000020694777,0.000033548007,0.011393848,0.000033218785,0.0025133225],"genre_scores_gemma":[0.9911322,0.00055889104,0.00068646995,0.00005619921,0.000016815122,0.00007773328,0.0072034704,0.00000412009,0.00026403682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995579,0.000090567635,0.00011200346,0.000073108145,0.00012887154,0.000037445723],"domain_scores_gemma":[0.99807453,0.0002449174,0.0009993145,0.000097401164,0.00039820193,0.00018563977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065812044,0.00018628153,0.00024890908,0.0013902407,0.00024837875,0.0003001338,0.0003581183,0.0002726946,0.0015545603],"category_scores_gemma":[0.0024359387,0.00013712877,0.00033326985,0.0013467375,0.000112291156,0.00031751607,0.00045601043,0.00035530698,0.00039903523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020789961,0.000013340921,0.9965868,0.000035030487,0.000053143125,0.000012724874,0.0000805634,0.000043546697,0.00007527661,0.000008122891,0.00041047987,0.002660172],"study_design_scores_gemma":[0.0000014553926,0.000016617658,0.9995408,0.000011374822,0.000013088845,0.000049346072,0.00009648923,0.000052197833,0.000015338366,0.000007340741,0.00019434729,0.0000015360448],"about_ca_topic_score_codex":0.014720616,"about_ca_topic_score_gemma":0.021608632,"teacher_disagreement_score":0.014720616,"about_ca_system_score_codex":0.00023836052,"about_ca_system_score_gemma":0.00022137334,"threshold_uncertainty_score":0.029269874},"labels":[],"label_agreement":null},{"id":"W2804123946","doi":"10.1177/2055217318778610","title":"Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3 Fingolimod Trials","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Fingolimod; Post-hoc analysis; Multiple sclerosis; Post hoc; Medicine; Internal medicine; Oncology; Psychiatry","score_opus":0.15633756185160314,"score_gpt":0.4018421928346263,"score_spread":0.24550463098302316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804123946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902818,0.006771908,0.0009891816,0.000112050635,0.0000678883,0.00033688397,0.0009791076,0.000035675985,0.00042557804],"genre_scores_gemma":[0.99701023,0.00072445883,0.00056578865,0.00011427027,0.00007449513,0.00035848506,0.0008611501,0.000020494173,0.00027050183],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9904227,0.007505871,0.0006773734,0.0006666548,0.00044374052,0.00028371764],"domain_scores_gemma":[0.9872019,0.008508275,0.0026527992,0.00080353173,0.00040369658,0.0004297654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0131843705,0.0006614966,0.002271921,0.0004727591,0.0001987303,0.0007601727,0.000440955,0.00048738718,0.0015707337],"category_scores_gemma":[0.009447038,0.00023508181,0.0051403963,0.0006278869,0.00035153228,0.0006056562,0.00046876044,0.0007418731,0.00013232406],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5735427,0.0008346449,0.2994643,0.0020180931,0.07452721,0.00033803502,0.00028104783,0.0030390515,0.004540615,0.00016872698,0.002190302,0.039055213],"study_design_scores_gemma":[0.03606808,0.07170255,0.82224166,0.00019886605,0.05378218,0.0006939903,0.00024498554,0.007427635,0.0030922962,0.00041513034,0.0040394757,0.00009321874],"about_ca_topic_score_codex":0.000384161,"about_ca_topic_score_gemma":0.0007486167,"teacher_disagreement_score":0.0131843705,"about_ca_system_score_codex":0.00029535053,"about_ca_system_score_gemma":0.0006163568,"threshold_uncertainty_score":0.06972647},"labels":[],"label_agreement":null},{"id":"W2805018524","doi":"10.1177/2055217318775236","title":"Clinical efficacy of teriflunomide over a fixed 2-year duration in the TOWER study","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"F. Hoffmann-La Roche; Sanofi","keywords":"Teriflunomide; Medicine; Context (archaeology); Multiple sclerosis; Clinical trial; Internal medicine; Physical therapy; Fingolimod; Immunology","score_opus":0.2095206560608331,"score_gpt":0.44714544103646325,"score_spread":0.23762478497563017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805018524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858677,0.0062027597,0.0005745386,0.00037922675,0.00022751468,0.001517839,0.001744672,0.00008265386,0.003403037],"genre_scores_gemma":[0.99296534,0.0012265786,0.0007004061,0.0004881627,0.00017493103,0.0015525228,0.001456326,0.000011914281,0.0014237928],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998461,0.00078761013,0.00015021843,0.00021516196,0.0001592544,0.00022673827],"domain_scores_gemma":[0.99750143,0.0004549154,0.0008608491,0.00033013857,0.00022569943,0.00062702934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005641296,0.00071535277,0.0018547465,0.0003728205,0.000539073,0.00090708846,0.0006343098,0.0013516324,0.003686947],"category_scores_gemma":[0.0042172777,0.00035057208,0.002204213,0.00044242,0.00051901786,0.0013104771,0.00047037314,0.0017702972,0.0007027957],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8961832,0.010535334,0.008471844,0.0010582248,0.0042841565,0.00013167686,0.00018823224,0.0014286083,0.0087219095,0.00021643403,0.0030348347,0.06574559],"study_design_scores_gemma":[0.39061925,0.5138331,0.0819617,0.00028032172,0.0041748323,0.00024763396,0.00012322805,0.0008428106,0.002849103,0.0003608359,0.004599817,0.000107350184],"about_ca_topic_score_codex":0.0011504326,"about_ca_topic_score_gemma":0.0043801134,"teacher_disagreement_score":0.005641296,"about_ca_system_score_codex":0.0010785459,"about_ca_system_score_gemma":0.0011075358,"threshold_uncertainty_score":0.02983439},"labels":[],"label_agreement":null},{"id":"W2889134371","doi":"10.1177/2055217318796684","title":"Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders","year":2018,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Deutsche Forschungsgemeinschaft","keywords":"Neuromyelitis optica; Medicine; Myelin oligodendrocyte glycoprotein; Multiple sclerosis; Neuropathic pain; Immunoglobulin G; Immunology; Internal medicine; Antibody; Anesthesia; Experimental autoimmune encephalomyelitis","score_opus":0.07959922474329705,"score_gpt":0.36002917611595747,"score_spread":0.2804299513726604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889134371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994011,0.0002777067,0.000026106905,0.000023414894,0.000004100283,0.000009161677,0.00008427333,7.8468787e-7,0.00017351331],"genre_scores_gemma":[0.9994578,0.0001742927,0.000071846596,0.000037188805,0.000017529763,0.000013332723,0.0001717441,4.670664e-7,0.000055919136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996531,0.00009259617,0.00005350603,0.0000666324,0.000057418594,0.00007672781],"domain_scores_gemma":[0.9993291,0.00015781436,0.00033939225,0.00001681771,0.000042175176,0.00011476762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048383363,0.0002773262,0.00036993966,0.0007415557,0.00035577847,0.00041302975,0.0002588133,0.0004781703,0.0022467747],"category_scores_gemma":[0.0016106686,0.00023862085,0.00029986925,0.0005688426,0.00032876665,0.000514479,0.00056720973,0.00033636804,0.00020001689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024353342,0.000104177285,0.9971602,0.000028165754,0.000023367917,0.0003580403,0.00008491333,0.000014424482,0.00043449795,0.0000070535966,0.000053404015,0.001488223],"study_design_scores_gemma":[0.000026491743,0.00033004003,0.9973036,0.000011999062,0.00001888814,0.0019347767,0.00018388423,0.0000491628,0.000043647684,0.000023592665,0.000071509974,0.0000023630078],"about_ca_topic_score_codex":0.0014632186,"about_ca_topic_score_gemma":0.0018140044,"teacher_disagreement_score":0.0022467747,"about_ca_system_score_codex":0.0002707555,"about_ca_system_score_gemma":0.00023439848,"threshold_uncertainty_score":0.0075162053},"labels":[],"label_agreement":null},{"id":"W2910743644","doi":"10.1177/2055217318824612","title":"Advanced imaging findings in progressive solitary sclerosis: a single lesion or a global disease?","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Genentech; Biogen","keywords":"Multiple sclerosis; White matter; Myelin; Pathology; Medicine; Lesion; Creatine; Corticospinal tract; Abnormality; Demyelinating disease; Magnetic resonance imaging; Internal medicine; Central nervous system; Radiology; Diffusion MRI; Immunology","score_opus":0.1647653451747893,"score_gpt":0.403542478242856,"score_spread":0.2387771330680667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910743644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969523,0.0010200347,0.0002584341,0.00004785518,0.0000056858353,0.000015194566,0.000056978017,0.000017638093,0.0016258082],"genre_scores_gemma":[0.9992943,0.00025085622,0.00026374508,0.000017599405,0.000019535648,0.0000029787893,0.00003758817,0.0000030953543,0.00011018621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987996,0.000021147811,0.000015153102,0.000033641492,0.00002856511,0.000021466401],"domain_scores_gemma":[0.9994382,0.0001185932,0.00020816473,0.000034047644,0.000051312843,0.00014967314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038372373,0.00050236733,0.0003855926,0.0017652131,0.00022205318,0.0003701764,0.00025326986,0.00039366266,0.0032426144],"category_scores_gemma":[0.0013123895,0.00016406339,0.00016254876,0.0006174466,0.00076624675,0.0005380492,0.0003785475,0.00026349016,0.00033852135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015843799,0.00013044075,0.84520465,0.00058242574,0.00022032578,0.07457787,0.0012032625,0.00024853743,0.045038555,0.00031331019,0.00043432156,0.030461857],"study_design_scores_gemma":[0.000048872083,0.0011405703,0.84317064,0.00010056832,0.00019125345,0.14930007,0.00064739835,0.00044310663,0.0039237575,0.00044345245,0.0005697111,0.000020566762],"about_ca_topic_score_codex":0.00073628785,"about_ca_topic_score_gemma":0.0012325271,"teacher_disagreement_score":0.0032426144,"about_ca_system_score_codex":0.00013564904,"about_ca_system_score_gemma":0.0001464493,"threshold_uncertainty_score":0.010847628},"labels":[],"label_agreement":null},{"id":"W2912932573","doi":"10.1177/2055217318823796","title":"Effect of different doses of gadolinium contrast agent on clinical outcomes in MS","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Lanthanide and Transition Metal Complexes","field":"Materials Science","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Statistics Canada; Ottawa Hospital; University of British Columbia","funders":"University of British Columbia; Acorda Therapeutics; Biogen","keywords":"Medicine; Cohort; Expanded Disability Status Scale; Demographics; Hazard ratio; Internal medicine; Adverse effect; Multiple sclerosis; Cohort study; Confidence interval; Demography; Psychiatry","score_opus":0.10232360738687998,"score_gpt":0.37066658720186113,"score_spread":0.2683429798149811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912932573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99627316,0.0030324021,0.00012810112,0.00005715257,0.000028169858,0.0000546187,0.000048620263,0.0000074073973,0.0003704545],"genre_scores_gemma":[0.99883014,0.0004613951,0.00028098043,0.000083594285,0.00008314697,0.000042238906,0.00006272601,0.000004470476,0.00015130345],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9971008,0.0018223625,0.00027147777,0.00022593951,0.000434891,0.00014455356],"domain_scores_gemma":[0.9943414,0.0033665567,0.0014553299,0.00023690368,0.00022948094,0.00037032476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044514444,0.0004238466,0.0010977952,0.00035629678,0.0002044141,0.0005609984,0.00029722988,0.00067394256,0.0006118608],"category_scores_gemma":[0.0065706396,0.00019984838,0.00062300224,0.0002623839,0.0003535141,0.00050147413,0.00023893458,0.0008149046,0.000086548076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6248916,0.010146971,0.11784938,0.00080751476,0.0034895272,0.0002967716,0.00019596858,0.0023543034,0.069462426,0.00011712448,0.00037018454,0.17001827],"study_design_scores_gemma":[0.02392281,0.57243925,0.36851743,0.00010181239,0.0025382086,0.00067030283,0.00013429715,0.0021603256,0.027293833,0.00026971268,0.0018887431,0.00006333623],"about_ca_topic_score_codex":0.00018022551,"about_ca_topic_score_gemma":0.00042673433,"teacher_disagreement_score":0.0044514444,"about_ca_system_score_codex":0.00022574372,"about_ca_system_score_gemma":0.00020063594,"threshold_uncertainty_score":0.023541749},"labels":[],"label_agreement":null},{"id":"W2920925212","doi":"10.1177/2055217319835226","title":"Does attendance at the ECTRIMS congress impact on therapeutic decisions in multiple sclerosis care?","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Sanofi Genzyme; Genentech; Multiple Sclerosis International Federation; Teva Pharmaceutical Industries","keywords":"Attendance; Medicine; Multiple sclerosis; Tolerability; Health care; Family medicine; Adverse effect; Psychiatry; Internal medicine","score_opus":0.4829953275870632,"score_gpt":0.4583553363929038,"score_spread":0.024639991194159383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2920925212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889859,0.0011347723,0.00022845186,0.006872894,0.00006357039,0.00002117533,0.0002716542,0.000010026442,0.002411512],"genre_scores_gemma":[0.9990031,0.00026152105,0.0001756657,0.00022757365,0.000065371285,0.000010206255,0.00008418732,0.0000026710213,0.00016970096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9829117,0.013351893,0.0007087107,0.0005025905,0.0014593829,0.0010657109],"domain_scores_gemma":[0.8339112,0.10521737,0.043775927,0.0028114172,0.0032990205,0.010985048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015785065,0.00016879303,0.00040714868,0.0008566386,0.00044364284,0.0018755498,0.0007419487,0.0011144255,0.0054433215],"category_scores_gemma":[0.13242674,0.00015866163,0.00066917314,0.0010388785,0.00055560784,0.0011041026,0.0012778906,0.0013459321,0.00042395812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087527075,0.000697829,0.94311297,0.00009723556,0.00025265856,0.00026813333,0.0006202537,0.0014744938,0.00006229839,0.0003930671,0.0024694363,0.049676225],"study_design_scores_gemma":[0.00003852735,0.00029278788,0.995572,0.00010016678,0.000058996135,0.00012162908,0.0007435136,0.0018517219,0.000043519947,0.00042269996,0.0007421028,0.000012396396],"about_ca_topic_score_codex":0.006909706,"about_ca_topic_score_gemma":0.00702561,"teacher_disagreement_score":0.015785065,"about_ca_system_score_codex":0.0016845457,"about_ca_system_score_gemma":0.0020761262,"threshold_uncertainty_score":0.08348042},"labels":[],"label_agreement":null},{"id":"W2922820066","doi":"10.1177/2055217319836664","title":"Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"National Institute of Neurological Disorders and Stroke; European Regional Development Fund; Chugai Pharmaceutical; Novartis Pharmaceuticals UK Limited; Georgia Clinical and Translational Science Alliance; Türk Nöroloji Derneği; Servier; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Türkiye Bilimsel ve Teknolojik Araştırma Kurumu; National Multiple Sclerosis Society; Genentech; Multiple Sclerosis Society; Action Medical Research; Novartis Pharma; Generalitat de Catalunya; EMD Serono; Zogenix; Mayo Foundation for Medical Education and Research; Alexion Pharmaceuticals; National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries; Biogen; Pfizer; Race to Erase MS; Acorda Therapeutics; Sanofi","keywords":"Magnetic resonance imaging; Medicine; Multiple sclerosis; Cerebrospinal fluid; Clinically isolated syndrome; Confidence interval; Prospective cohort study; McDonald criteria; Radiology; Pathology; Internal medicine; Immunology","score_opus":0.09120027534748268,"score_gpt":0.33570227344725173,"score_spread":0.24450199809976905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922820066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874866,0.00045750552,0.00012348256,0.0000440849,0.000009878599,0.0000056940603,0.00006752639,0.0000071284167,0.00053606514],"genre_scores_gemma":[0.99955493,0.00008180707,0.00020290626,0.000015019503,0.000014435219,0.0000042221714,0.000085191234,0.0000030646345,0.00003833763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831957,0.0004665094,0.00024368572,0.00032529238,0.00044359657,0.00020127946],"domain_scores_gemma":[0.9870618,0.0046465336,0.005937597,0.00051859237,0.0009054181,0.00093006203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002173976,0.00080080784,0.00042543781,0.0014673147,0.00026228858,0.0008658824,0.00062487036,0.0009375553,0.0016479149],"category_scores_gemma":[0.015866755,0.00039209973,0.0007024515,0.00065456313,0.000811485,0.0008751353,0.0008318527,0.0010485651,0.0004832471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044196146,0.000006630646,0.9988827,0.00000514998,0.000019518442,0.0000807993,0.00003722679,0.00005074261,0.00023437089,0.000008082014,0.000028178589,0.00060238026],"study_design_scores_gemma":[0.0000054901575,0.00008111556,0.99732095,0.000016819264,0.00004179092,0.0016764144,0.00010781274,0.00036885458,0.00022736927,0.0000273102,0.0001217762,0.000004320277],"about_ca_topic_score_codex":0.002958142,"about_ca_topic_score_gemma":0.0031828287,"teacher_disagreement_score":0.002958142,"about_ca_system_score_codex":0.0003654189,"about_ca_system_score_gemma":0.0004658161,"threshold_uncertainty_score":0.0114972},"labels":[],"label_agreement":null},{"id":"W2942919250","doi":"10.1177/2055217319844796","title":"Multicentre assessment of motor and sensory evoked potentials in multiple sclerosis: reliability and implications for clinical trials","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Clinique Neuro-Outaouais","funders":"Schweizerische Multiple Sklerose Gesellschaft; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Bayer HealthCare; Biogen","keywords":"Multiple sclerosis; Audiology; Remyelination; Medicine; Clinical trial; Psychology; Physical medicine and rehabilitation; Analysis of variance; Internal medicine; Physical therapy; Central nervous system","score_opus":0.4143189573992716,"score_gpt":0.49663277993960214,"score_spread":0.08231382254033054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942919250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8348486,0.09755233,0.03288891,0.0066405977,0.0017023615,0.017961208,0.0012932605,0.00031071022,0.0068020024],"genre_scores_gemma":[0.96816057,0.002588974,0.019022401,0.0011950426,0.000515002,0.0076812166,0.0005877767,0.000027989907,0.00022106634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.71758336,0.24686436,0.017356277,0.006135134,0.010792952,0.0012680347],"domain_scores_gemma":[0.5830108,0.30867994,0.05404644,0.023011789,0.026303237,0.004947853],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.25592518,0.001073339,0.003675279,0.0015586895,0.0008441958,0.0024160382,0.0016026985,0.0048232195,0.0008284311],"category_scores_gemma":[0.33416355,0.0007112026,0.0023467913,0.0025637883,0.0025172506,0.0028102307,0.0020978844,0.002306298,0.00037095233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27786845,0.0038726863,0.41194788,0.007886823,0.016668078,0.0003060815,0.0018168164,0.0076121916,0.0065909545,0.002111638,0.003374861,0.2599436],"study_design_scores_gemma":[0.08873664,0.14009325,0.714643,0.0042737545,0.012044318,0.0010456708,0.00062138564,0.017711233,0.0039927335,0.006275895,0.010145327,0.0004167893],"about_ca_topic_score_codex":0.0005456762,"about_ca_topic_score_gemma":0.00079601316,"teacher_disagreement_score":0.25592518,"about_ca_system_score_codex":0.0012027594,"about_ca_system_score_gemma":0.0022419987,"threshold_uncertainty_score":0.91757673},"labels":[],"label_agreement":null},{"id":"W2971369168","doi":"10.1177/2055217319871582","title":"Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Instituto de Salud Carlos III; Sanofi Genzyme; Chugai Pharmaceutical; Novartis Pharma; Ipsen; Moorfields Eye Hospital NHS Foundation Trust; Deutsche Forschungsgemeinschaft; Sanofi; Bayer HealthCare; Genentech; Multiple Sclerosis Society; Alexion Pharmaceuticals; Merz Pharmaceuticals; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Celgene; Biogen; University College London; Allergan; Arthur Arnstein Stiftung","keywords":"Multiple sclerosis; Medicine; Optic neuritis; Retinal; Inner nuclear layer; Inner plexiform layer; Ophthalmology; Internal medicine; Neurodegeneration; Disease; Pathology; Immunology","score_opus":0.20663405230788706,"score_gpt":0.3833640099548292,"score_spread":0.17672995764694216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971369168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993018,0.00018561384,0.000091364986,0.000016762391,0.0000021704448,0.000007698911,0.00020083677,0.00000373136,0.00019002696],"genre_scores_gemma":[0.99959356,0.0000399368,0.000093000475,0.000010603554,0.0000052301025,0.000007079993,0.00019082168,0.0000012690133,0.000058528272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995788,0.0001082752,0.0000495102,0.0001235925,0.000079637284,0.000060313556],"domain_scores_gemma":[0.99716586,0.00029385125,0.0017430229,0.00017680468,0.00033399448,0.00028644886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011532464,0.00025921754,0.00023073849,0.0009094372,0.00032896697,0.00064645003,0.0003085592,0.00043500646,0.00080085057],"category_scores_gemma":[0.0026999575,0.00021212267,0.0002876417,0.00077798846,0.00027775596,0.0007337763,0.00046079585,0.0004736432,0.00020293993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010277127,0.00002044261,0.9989065,0.000003677349,0.000030759486,0.00002691452,0.000035575005,0.000023451856,0.00023329713,0.0000035291173,0.00002303399,0.00059001864],"study_design_scores_gemma":[0.0000031006111,0.00007709477,0.9993814,0.0000024344265,0.000017663844,0.0002169093,0.00004469782,0.000115091934,0.000071689785,0.000008642331,0.000059133446,0.0000021983692],"about_ca_topic_score_codex":0.002653737,"about_ca_topic_score_gemma":0.002986795,"teacher_disagreement_score":0.002653737,"about_ca_system_score_codex":0.00032082945,"about_ca_system_score_gemma":0.0002428424,"threshold_uncertainty_score":0.0060990453},"labels":[],"label_agreement":null},{"id":"W2976176272","doi":"10.1177/2055217319869360","title":"Cannabis-based product use in a multiple sclerosis cohort","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Demographics; Cohort; Cannabis; Multiple sclerosis; Medical record; Disease; Retrospective cohort study; Internal medicine; Family medicine; Psychiatry; Demography","score_opus":0.1555334950228032,"score_gpt":0.3546816758158016,"score_spread":0.19914818079299842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976176272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990759,0.00011960769,0.000018637826,0.000033846823,0.0000035349406,0.000010079448,0.00040080107,0.0000016879407,0.00033585588],"genre_scores_gemma":[0.9990349,0.00016568044,0.000038977818,0.00004564232,0.000009713632,0.000010249733,0.00039162085,0.0000027306082,0.00030050994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965477,0.000044511704,0.00002567193,0.00009979837,0.00009902032,0.000076313074],"domain_scores_gemma":[0.99935967,0.00005171182,0.00026433496,0.000040797433,0.00009227538,0.00019111374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031442687,0.00022741103,0.00039969577,0.0008863989,0.00097406795,0.0009085931,0.00028931999,0.00031125525,0.0018355525],"category_scores_gemma":[0.0011553179,0.00026681193,0.00031750544,0.0010003428,0.00023512283,0.0005310972,0.00056083157,0.0006185955,0.0003921341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067711495,0.000031934997,0.99854255,0.000004948489,0.0000202553,0.00011425897,0.00016668349,0.000010096949,0.0002308775,0.000010280012,0.00009756381,0.0007028273],"study_design_scores_gemma":[0.0000046221894,0.00006738114,0.99864024,0.0000062661197,0.00001448554,0.00050987286,0.00042761475,0.00006068159,0.000033208522,0.000011249624,0.00022081252,0.0000036485178],"about_ca_topic_score_codex":0.022155745,"about_ca_topic_score_gemma":0.02031523,"teacher_disagreement_score":0.022155745,"about_ca_system_score_codex":0.00031407515,"about_ca_system_score_gemma":0.00046443543,"threshold_uncertainty_score":0.044053555},"labels":[],"label_agreement":null},{"id":"W2980707925","doi":"10.1177/2055217319879952","title":"Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Chugai Pharmaceutical; Multiple Sclerosis Society of Canada; Acorda Therapeutics; EMD Serono; Vancouver Coastal Health Research Institute; Michael Smith Health Research BC; Vertex Pharmaceuticals; Multiple Sclerosis Society; Sanofi Genzyme; F. Hoffmann-La Roche; Teva Pharmaceutical Industries; Biogen; Celgene; Sanofi","keywords":"Ocrelizumab; Gliosis; Medicine; Interferon beta; Magnetic resonance imaging; Multiple sclerosis; Internal medicine; Oncology; Nuclear magnetic resonance; Immunology; Pathology; Radiology; Physics","score_opus":0.20204028880489555,"score_gpt":0.4063018138214152,"score_spread":0.20426152501651967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980707925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994486,0.00026053912,0.00001567416,0.000024796705,0.0000035858686,0.0000049767673,0.000024479365,0.000002072869,0.00021527291],"genre_scores_gemma":[0.99962616,0.0000629199,0.000038590355,0.000042064778,0.000007191248,0.0000064433166,0.00007362967,8.213552e-7,0.00014215818],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998659,0.000033119686,0.000018539346,0.000033484404,0.000019890573,0.000028931176],"domain_scores_gemma":[0.9993606,0.00012444846,0.00023480973,0.00003874481,0.000075046904,0.00016629146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046370795,0.00016797581,0.0005135072,0.00022753139,0.00020211999,0.00025733057,0.00013968868,0.00039922431,0.0011317121],"category_scores_gemma":[0.0010387448,0.000113426846,0.00023692219,0.00014417653,0.0001762349,0.00019093238,0.00011253749,0.00036171454,0.00016965905],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07283049,0.0015818101,0.7835613,0.00014631647,0.00052315707,0.0017305039,0.00054256653,0.00038690813,0.09207137,0.000052128715,0.00045064563,0.046122838],"study_design_scores_gemma":[0.0006471824,0.012458812,0.9818751,0.00001442589,0.00018875106,0.0011809295,0.00016710875,0.00023260391,0.002754833,0.000040235314,0.00043144362,0.00000841567],"about_ca_topic_score_codex":0.00068020745,"about_ca_topic_score_gemma":0.00078266085,"teacher_disagreement_score":0.0011317121,"about_ca_system_score_codex":0.00023846257,"about_ca_system_score_gemma":0.00015032239,"threshold_uncertainty_score":0.0037859678},"labels":[],"label_agreement":null},{"id":"W2984612893","doi":"10.1177/2055217319885983","title":"Machine learning in secondary progressive multiple sclerosis: an improved predictive model for short-term disability progression","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"Expanded Disability Status Scale; Logistic regression; Multiple sclerosis; Machine learning; Medicine; Receiver operating characteristic; Support vector machine; Clinical trial; Physical therapy; Artificial intelligence; Internal medicine; Computer science","score_opus":0.1566684101755616,"score_gpt":0.4037198011592445,"score_spread":0.2470513909836829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984612893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8843246,0.0027596266,0.10816355,0.0013425141,0.0001313874,0.0001722467,0.000862228,0.00056817656,0.001675694],"genre_scores_gemma":[0.987525,0.00032279422,0.011009772,0.000112102774,0.00007236815,0.00008129419,0.00044222162,0.000015730586,0.0004187517],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991868,0.00047181424,0.000045316006,0.00012653423,0.000109219225,0.000060326885],"domain_scores_gemma":[0.99591666,0.0031236692,0.00033911815,0.00017576966,0.000337217,0.00010764379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004205993,0.0006540009,0.0009699095,0.0009078882,0.00017768177,0.00076368195,0.0005216385,0.0006489287,0.001053873],"category_scores_gemma":[0.00870579,0.00014088336,0.0007872686,0.000456587,0.00020256586,0.00055500685,0.000447101,0.0011082413,0.0002691592],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031939542,0.00086327526,0.16943574,0.0002497703,0.0008702701,0.00019240775,0.000109395856,0.5905226,0.002433052,0.0011524891,0.003981962,0.22699513],"study_design_scores_gemma":[0.00008559084,0.00054583146,0.013502995,0.000037400245,0.000119208504,0.000074077005,0.00001125001,0.9835169,0.00047065466,0.0012449854,0.00037655316,0.000014677537],"about_ca_topic_score_codex":0.002370784,"about_ca_topic_score_gemma":0.001887759,"teacher_disagreement_score":0.004205993,"about_ca_system_score_codex":0.0004701313,"about_ca_system_score_gemma":0.00070686487,"threshold_uncertainty_score":0.022243679},"labels":[],"label_agreement":null},{"id":"W2993353083","doi":"10.1177/2055217319887191","title":"Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing–remitting multiple sclerosis in a real-world clinical setting: PROTEC","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; McGill University; Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Dimethyl fumarate; Medicine; Multiple sclerosis; Relapsing remitting; Internal medicine; Clinical trial; Observational study; Physical therapy; Disease; Immunology","score_opus":0.11693464970568275,"score_gpt":0.3796222440385658,"score_spread":0.2626875943328831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2993353083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984768,0.0011294407,0.000035553698,0.000038277984,0.000008447652,0.000026376301,0.00011863955,0.00000401212,0.00016241781],"genre_scores_gemma":[0.99948573,0.0001411338,0.00011510943,0.000027133838,0.00001495877,0.00003115479,0.0001402984,8.195233e-7,0.000043507123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720865,0.0017950685,0.0001881457,0.00031973026,0.0003347804,0.00015363957],"domain_scores_gemma":[0.995304,0.0016397388,0.001908641,0.00023239481,0.0003447698,0.0005705259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004845228,0.00043851623,0.0011160445,0.00036950895,0.0003135797,0.0006322438,0.00037035462,0.00042984026,0.00056011573],"category_scores_gemma":[0.006155153,0.00016272244,0.0009258086,0.00038310947,0.00033318886,0.00054193824,0.00056197617,0.00052191556,0.00008159866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16301246,0.004465253,0.73523045,0.0007600119,0.0034458386,0.0000972125,0.00042879695,0.0011545096,0.0031218096,0.00006907831,0.00061432726,0.08760032],"study_design_scores_gemma":[0.005664049,0.05296403,0.93592274,0.00008146324,0.0013665018,0.0002257298,0.0001826254,0.00185504,0.0008770058,0.00006523209,0.00074727455,0.000048278765],"about_ca_topic_score_codex":0.0016189173,"about_ca_topic_score_gemma":0.0024462303,"teacher_disagreement_score":0.004845228,"about_ca_system_score_codex":0.00060993043,"about_ca_system_score_gemma":0.0005911517,"threshold_uncertainty_score":0.025624335},"labels":[],"label_agreement":null},{"id":"W2995950133","doi":"10.1177/2055217319894360","title":"Identifying people with multiple sclerosis in the Canadian Primary Care Sentinel Surveillance Network","year":2019,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"Research Manitoba","keywords":"Medicine; Multiple sclerosis; Medical diagnosis; Primary care; Epidemiology; Cohort; Population; Medical prescription; Family medicine; Internal medicine; Pathology; Environmental health; Nursing","score_opus":0.12411031433271204,"score_gpt":0.34055021199178576,"score_spread":0.21643989765907373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995950133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84020245,0.0075895097,0.0062363017,0.004963841,0.00030524415,0.003086023,0.117228076,0.0001929584,0.02019554],"genre_scores_gemma":[0.9577264,0.002062453,0.009026927,0.0010529435,0.00007637742,0.00085084426,0.028335402,0.000018719555,0.00084991165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99140525,0.0014468954,0.000858644,0.0012844848,0.0038292543,0.0011754542],"domain_scores_gemma":[0.9839717,0.0013199009,0.0026203531,0.0009744771,0.009931977,0.0011815076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008857024,0.0005588636,0.0005716575,0.003820556,0.0022383225,0.0014342067,0.0025751488,0.00053402944,0.0014568313],"category_scores_gemma":[0.026424905,0.00033497214,0.00081431115,0.0053788195,0.00057336816,0.00047407165,0.0019112198,0.00066512363,0.00022006435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011512688,0.00003193384,0.9679165,0.0004277825,0.00023658913,0.00013592806,0.00083418994,0.0004176102,0.00020672544,0.0006364152,0.016466508,0.012574601],"study_design_scores_gemma":[0.000044208668,0.00003830355,0.98794985,0.0004139175,0.00017860562,0.00016006976,0.00077063864,0.0013283677,0.0002402606,0.00022198574,0.008630744,0.000023078428],"about_ca_topic_score_codex":0.97841555,"about_ca_topic_score_gemma":0.98325795,"teacher_disagreement_score":0.025554387,"about_ca_system_score_codex":0.025554387,"about_ca_system_score_gemma":0.04509459,"threshold_uncertainty_score":0.18541092},"labels":[],"label_agreement":null},{"id":"W3012254007","doi":"10.1177/2055217320911939","title":"An exploratory analysis of the efficacy of ocrelizumab in patients with multiple sclerosis with increased disability","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Allergan; EMD Serono; Genentech; MedDay Pharmaceuticals; Sanofi; Bayer HealthCare; Chugai Pharmaceutical; Mallinckrodt Pharmaceuticals; Acorda Therapeutics; Mylan; TG Therapeutics; Sanofi Genzyme; F. Hoffmann-La Roche; Teva Pharmaceutical Industries; Biogen; Celgene; University of Texas Health Science Center at Houston","keywords":"Ocrelizumab; Medicine; Expanded Disability Status Scale; Multiple sclerosis; Placebo; Internal medicine; Interferon beta-1a; Oncology; Clinical trial; Physical therapy; Immunology; Pathology; Rituximab; Alternative medicine","score_opus":0.12643456212150755,"score_gpt":0.345705107309352,"score_spread":0.21927054518784445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012254007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953151,0.001858891,0.00053817686,0.00010772681,0.00002599293,0.0007108733,0.0006451535,0.0000173087,0.00078083976],"genre_scores_gemma":[0.9971693,0.00023155863,0.00074056373,0.000102876584,0.000048785416,0.000672956,0.0007306244,0.0000053303575,0.00029809718],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99591196,0.0029350359,0.00023761347,0.00041220838,0.00025741142,0.00024583226],"domain_scores_gemma":[0.99291754,0.0045946813,0.0012571173,0.0005504003,0.00030557797,0.00037464593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005891066,0.0010951327,0.0014527418,0.00060782937,0.00030917345,0.00056068326,0.0005074324,0.0006119679,0.0027477946],"category_scores_gemma":[0.0070895846,0.0002621656,0.0034425408,0.00045469264,0.00054912764,0.0004694479,0.00051984395,0.0007194226,0.00023247462],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88568074,0.005870607,0.059361417,0.0015902997,0.0121450825,0.00051599473,0.00026052908,0.0016707645,0.0076080197,0.00036403607,0.0010616198,0.023870995],"study_design_scores_gemma":[0.18621434,0.5440745,0.23267199,0.0002138609,0.018546376,0.001119792,0.00036504667,0.0040535727,0.0065660705,0.0009541744,0.005120779,0.00009957612],"about_ca_topic_score_codex":0.0002038761,"about_ca_topic_score_gemma":0.0003780671,"teacher_disagreement_score":0.005891066,"about_ca_system_score_codex":0.00057217234,"about_ca_system_score_gemma":0.00092993415,"threshold_uncertainty_score":0.031155348},"labels":[],"label_agreement":null},{"id":"W3015049303","doi":"10.1177/2055217320907951","title":"The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing–remitting multiple sclerosis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Fingolimod; Medicine; Multiple sclerosis; Expanded Disability Status Scale; Magnetic resonance imaging; Relapsing remitting; Internal medicine; Physical therapy; Pediatrics; Immunology","score_opus":0.17645691073053707,"score_gpt":0.382740791297774,"score_spread":0.20628388056723693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015049303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566096,0.0018497048,0.00018181515,0.00017661734,0.000056227855,0.00031450993,0.0009782284,0.000011670438,0.00077019486],"genre_scores_gemma":[0.99646664,0.0008466492,0.00038516344,0.00040718046,0.00016538065,0.00038287306,0.0008821096,0.000005940752,0.00045821676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873406,0.000683104,0.0001322908,0.0002286879,0.00012736606,0.00009443458],"domain_scores_gemma":[0.99710745,0.0003993226,0.0013054316,0.00027751626,0.00027445503,0.00063582044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036671513,0.0005591708,0.0010483599,0.00030811533,0.00037884476,0.00085730496,0.000464121,0.0006066287,0.0014628884],"category_scores_gemma":[0.0026435382,0.0003404045,0.0008644262,0.00048305202,0.00030995556,0.0006671698,0.0007296132,0.00076357165,0.00023777511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34805068,0.01004127,0.55520535,0.0013807241,0.008967937,0.00049711944,0.00085002714,0.00047183037,0.0104879225,0.00020179598,0.0032031848,0.060642146],"study_design_scores_gemma":[0.08124347,0.08986137,0.81171864,0.00025028072,0.008366598,0.0008898281,0.00042049977,0.0006748976,0.0017172669,0.00017269608,0.0046190354,0.000065417145],"about_ca_topic_score_codex":0.0007429736,"about_ca_topic_score_gemma":0.0011479039,"teacher_disagreement_score":0.0036671513,"about_ca_system_score_codex":0.00038119106,"about_ca_system_score_gemma":0.0007689338,"threshold_uncertainty_score":0.01939398},"labels":[],"label_agreement":null},{"id":"W3040620803","doi":"10.1177/2055217320926613","title":"Short-term outcomes of pediatric multiple sclerosis patients treated with alemtuzumab at a Canadian University multiple sclerosis clinic","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Alemtuzumab; Multiple sclerosis; Medicine; Expanded Disability Status Scale; Pediatrics; Internal medicine; Psychiatry; Transplantation","score_opus":0.21394610092173535,"score_gpt":0.3359127337161579,"score_spread":0.12196663279442252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040620803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996527,0.0015274971,0.00004847212,0.00026327145,0.000012368331,0.00001594119,0.00034689202,0.000003979042,0.0012546127],"genre_scores_gemma":[0.9985417,0.00060901785,0.00005755964,0.000082755396,0.000018248655,0.000009290788,0.0004762694,0.0000017876819,0.00020327437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954754,0.000061016435,0.00003503592,0.00003570119,0.00014603883,0.00017454223],"domain_scores_gemma":[0.9977301,0.00018033074,0.00070758985,0.000032392963,0.00044968186,0.0008999287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036235596,0.00018347678,0.0003592392,0.0003753461,0.0010679831,0.00066077174,0.00034765626,0.00032886726,0.0008029152],"category_scores_gemma":[0.0022279774,0.00007448403,0.00034747878,0.0006650824,0.00034727596,0.00027983906,0.00036314045,0.0006749829,0.00014769954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077451696,0.00020403149,0.9781738,0.000047253274,0.000090710666,0.0015846163,0.0005665228,0.00016455166,0.00054538244,0.00005763535,0.0007239766,0.017067008],"study_design_scores_gemma":[0.00003297809,0.0010754894,0.9949988,0.000041328934,0.00011125341,0.0017031352,0.00053921726,0.00014184896,0.00019578218,0.000034269033,0.0011096948,0.000016095059],"about_ca_topic_score_codex":0.12381677,"about_ca_topic_score_gemma":0.17568213,"teacher_disagreement_score":0.12381677,"about_ca_system_score_codex":0.002961108,"about_ca_system_score_gemma":0.0031295472,"threshold_uncertainty_score":0.24619222},"labels":[],"label_agreement":null},{"id":"W3092637296","doi":"10.1177/2055217320959806","title":"Environmental enrichment alleviates the deleterious effects of stress in experimental autoimmune encephalomyelitis","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fondation pour la Recherche Médicale; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques","keywords":"Multiple sclerosis; Experimental autoimmune encephalomyelitis; Encephalomyelitis; Medicine; Incidence (geometry); Animal model; Immunology; Internal medicine","score_opus":0.08212622809739435,"score_gpt":0.33615484850536415,"score_spread":0.2540286204079698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092637296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981021,0.00059456524,0.00043085817,0.00006985773,0.000028790984,0.00001573116,0.00006907639,0.00007715927,0.00061184],"genre_scores_gemma":[0.99635774,0.00078628166,0.0012331372,0.000078725665,0.000042458865,0.000042024796,0.00022159444,0.000018589633,0.001219516],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989593,0.000025794807,0.000010250801,0.000012953435,0.000019085746,0.000036047328],"domain_scores_gemma":[0.9997919,0.00002236017,0.000055783665,0.000022014177,0.000017643299,0.00009034925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011143748,0.0005139225,0.0003259985,0.0002508448,0.00018681087,0.00022953471,0.00016506844,0.00019063077,0.0015155821],"category_scores_gemma":[0.00019530562,0.0001005152,0.00018976626,0.000095574454,0.00027687656,0.0001292932,0.00028490231,0.00054665044,0.00019953649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033660457,0.0012929646,0.0016593202,0.00022401099,0.00005293473,0.00015660874,0.000102951984,0.00015074194,0.9765732,0.00009220436,0.00015780785,0.01617114],"study_design_scores_gemma":[0.0005550638,0.051258545,0.14139639,0.00022444117,0.00031054052,0.0010444463,0.00053085486,0.0016862007,0.79517794,0.00065016706,0.0071145967,0.000050771636],"about_ca_topic_score_codex":0.00025958853,"about_ca_topic_score_gemma":0.0006896533,"teacher_disagreement_score":0.0015155821,"about_ca_system_score_codex":0.00009376727,"about_ca_system_score_gemma":0.00020341476,"threshold_uncertainty_score":0.0050700903},"labels":[],"label_agreement":null},{"id":"W3093363057","doi":"10.1177/2055217320964940","title":"The feasibility of assessing cognitive and motor function in multiple sclerosis patients using robotics","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Canadian Institutes of Health Research; GlaxoSmithKline","keywords":"Robotics; Multiple sclerosis; Cognition; Motor function; Artificial intelligence; Physical medicine and rehabilitation; Motor learning; Psychology; Neuroscience; Computer science; Medicine; Robot; Psychiatry","score_opus":0.42009798668849724,"score_gpt":0.4216420065188642,"score_spread":0.0015440198303669495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093363057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787104,0.00019809708,0.0006638802,0.000045445464,0.0000066145685,0.0000680516,0.00007472674,0.000012545244,0.0010595733],"genre_scores_gemma":[0.9984913,0.000055123248,0.0012227598,0.000023718956,0.0000051548395,0.000051476305,0.000051876526,0.0000012412054,0.00009741404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988727,0.00050812383,0.00011895912,0.00015554456,0.00026632537,0.000078253746],"domain_scores_gemma":[0.9974685,0.0010725416,0.00063086377,0.00013372369,0.00051996927,0.00017447078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025749467,0.00035669954,0.00021371631,0.00056228635,0.00027393183,0.0005585246,0.00022351247,0.00040307097,0.0012618942],"category_scores_gemma":[0.0070507545,0.00012849321,0.00030473468,0.00021232785,0.00032293552,0.00052294857,0.0006607443,0.00023795609,0.0003754504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001586406,0.00039958613,0.93595564,0.00014520601,0.00008303643,0.00016568157,0.00066563685,0.00044357553,0.004178475,0.00004576402,0.0002227857,0.05610812],"study_design_scores_gemma":[0.00008843264,0.004899604,0.9878368,0.000070197704,0.00007011708,0.0012879267,0.0007933188,0.0022877997,0.0017572169,0.00014457773,0.00072990236,0.000034258017],"about_ca_topic_score_codex":0.00079113076,"about_ca_topic_score_gemma":0.0013819226,"teacher_disagreement_score":0.0025749467,"about_ca_system_score_codex":0.00019374947,"about_ca_system_score_gemma":0.00034448385,"threshold_uncertainty_score":0.013617814},"labels":[],"label_agreement":null},{"id":"W3116218681","doi":"10.1177/2055217320972137","title":"Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years","year":2020,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Sanofi","keywords":"Alemtuzumab; Medicine; Multiple sclerosis; Expanded Disability Status Scale; Internal medicine; Confidence interval; Relapsing remitting; Progressive disease; Disease; Immunology; Transplantation","score_opus":0.16019352899797554,"score_gpt":0.34929165858651756,"score_spread":0.18909812958854202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116218681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905986,0.0003888295,0.000060034457,0.000014994966,0.0000046820046,0.000013895983,0.0001733755,0.0000035183032,0.0002808722],"genre_scores_gemma":[0.99941313,0.000076352495,0.000026571157,0.000030348629,0.000004483857,0.000011202948,0.0002779355,0.0000013195043,0.00015860592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890304,0.00036430676,0.00011506011,0.00026814546,0.0002324453,0.00011699068],"domain_scores_gemma":[0.99813396,0.00047682194,0.00082347216,0.00016309453,0.0001411988,0.0002614451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012313214,0.00017008327,0.00046952022,0.00043542005,0.00024827127,0.000584042,0.00030264084,0.00033055933,0.0010846355],"category_scores_gemma":[0.0024264904,0.00015007176,0.00069725653,0.0003605612,0.00017535724,0.0002737843,0.00027435657,0.000574698,0.00019102944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027471674,0.00013431825,0.99044997,0.00002618046,0.0002975034,0.00024697132,0.00010305552,0.0001407525,0.00087127957,0.000020728035,0.00016240269,0.004799699],"study_design_scores_gemma":[0.000094483454,0.00058504555,0.997598,0.000011448935,0.00012832995,0.00067178364,0.00007575267,0.00022188466,0.00032422197,0.000021776192,0.0002621381,0.0000052018804],"about_ca_topic_score_codex":0.0012134012,"about_ca_topic_score_gemma":0.00089385983,"teacher_disagreement_score":0.0012313214,"about_ca_system_score_codex":0.00024782596,"about_ca_system_score_gemma":0.00020772697,"threshold_uncertainty_score":0.0065119863},"labels":[],"label_agreement":null},{"id":"W3134392354","doi":"10.1177/2055217321990852","title":"Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"EMD Serono","keywords":"Cladribine; Multiple sclerosis; Medicine; Placebo; Lesion; Magnetic resonance imaging; Nuclear medicine; Post-hoc analysis; Internal medicine; Radiology; Surgery; Pathology","score_opus":0.2575479572732252,"score_gpt":0.42546085738620326,"score_spread":0.16791290011297805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134392354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813396,0.00084911304,0.00005118058,0.000045851903,0.000010856375,0.000072225484,0.00042058804,0.000007152642,0.00040912788],"genre_scores_gemma":[0.99785966,0.00044409937,0.00031457742,0.000059337213,0.00003922631,0.00008224772,0.0008920085,0.0000030427,0.00030583164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996371,0.00017370812,0.000033863347,0.000059022073,0.00005586989,0.000040399846],"domain_scores_gemma":[0.99893206,0.00014010494,0.00047501418,0.000081409074,0.000089743895,0.00028162397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015264853,0.00054709066,0.0010926463,0.00016855999,0.00017345414,0.00045243837,0.00033020403,0.00047885996,0.0013340159],"category_scores_gemma":[0.0015530111,0.00016554778,0.00067669555,0.00022266482,0.00019585463,0.0002638303,0.00039311397,0.000538133,0.00016830383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43605793,0.0036506788,0.4999988,0.0010272504,0.002503958,0.0003792085,0.00032917626,0.00048283354,0.01401222,0.00013108997,0.0010269444,0.04039989],"study_design_scores_gemma":[0.018707989,0.03584641,0.9391524,0.00012852061,0.002194135,0.00047938913,0.00013034795,0.00042508947,0.0014254285,0.00010909931,0.0013682117,0.00003300623],"about_ca_topic_score_codex":0.0008760794,"about_ca_topic_score_gemma":0.0015535607,"teacher_disagreement_score":0.0015264853,"about_ca_system_score_codex":0.00017368403,"about_ca_system_score_gemma":0.0002699765,"threshold_uncertainty_score":0.008072972},"labels":[],"label_agreement":null},{"id":"W3168177144","doi":"10.1177/20552173211015503","title":"Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Race to Erase MS; Mallinckrodt Pharmaceuticals; National Multiple Sclerosis Society","keywords":"Medicine; Expanded Disability Status Scale; Multiple sclerosis; Disease; Pediatrics; Physical therapy; Internal medicine; Psychiatry","score_opus":0.1422290573835009,"score_gpt":0.3898073066572257,"score_spread":0.2475782492737248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168177144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964444,0.0026349088,0.000118521544,0.00014568225,0.00000721607,0.000010040942,0.000134088,0.000009400146,0.00049571705],"genre_scores_gemma":[0.999522,0.00020026814,0.000045671888,0.000015804208,0.000013320133,0.0000042980023,0.00011981673,0.000001999729,0.00007682911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988188,0.00059296825,0.00010180427,0.00012469443,0.00020069547,0.00016095254],"domain_scores_gemma":[0.9928646,0.0030765368,0.0025986717,0.00028659264,0.000280439,0.0008932167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025641848,0.00029575825,0.0006003587,0.00045516837,0.00023473219,0.0004220872,0.00035175402,0.00043727542,0.0014917245],"category_scores_gemma":[0.008316486,0.00010378036,0.0010843668,0.0003525633,0.0003809838,0.00039413615,0.00042591058,0.0007145757,0.00020566513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023543055,0.00022933015,0.9831851,0.000051584546,0.0004732845,0.0000935641,0.000054969987,0.00036329046,0.00026298873,0.000026098605,0.000097921446,0.012807578],"study_design_scores_gemma":[0.000014927684,0.0007093913,0.99819463,0.00001842815,0.00012688023,0.00021010183,0.00003351731,0.000478925,0.00007805176,0.00004093114,0.00008958379,0.000004585546],"about_ca_topic_score_codex":0.0013223712,"about_ca_topic_score_gemma":0.0015189426,"teacher_disagreement_score":0.0025641848,"about_ca_system_score_codex":0.0002867119,"about_ca_system_score_gemma":0.00034607324,"threshold_uncertainty_score":0.013560891},"labels":[],"label_agreement":null},{"id":"W3180459776","doi":"10.1177/20552173211029672","title":"Prioritizing the healthcare access concerns of Canadians with MS","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Health care; Descriptive statistics; Quality (philosophy); Business; Medicine; Nursing; Family medicine; Political science","score_opus":0.2766300272571652,"score_gpt":0.4396019545093432,"score_spread":0.16297192725217802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180459776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9706755,0.0012988248,0.00033266738,0.010109838,0.00007280236,0.000116288575,0.0010182359,0.000017355467,0.016358387],"genre_scores_gemma":[0.99701345,0.00067787006,0.00038718374,0.0008011746,0.000014522991,0.000023903662,0.00025816594,0.0000040034934,0.0008197845],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9973943,0.00037070198,0.00011371495,0.00013926631,0.00096468284,0.0010173798],"domain_scores_gemma":[0.9931202,0.0007827154,0.0012410348,0.00009072867,0.002951359,0.0018139642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00258932,0.0002980076,0.0003241647,0.001564021,0.0070313173,0.0019390999,0.00070607476,0.0006541998,0.0041388078],"category_scores_gemma":[0.009542303,0.00017975921,0.00059330737,0.0022295848,0.001344802,0.0011118111,0.0018383983,0.0013180408,0.00015837127],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031772206,0.00015926058,0.77461696,0.0007037691,0.00011440083,0.0010535722,0.11588981,0.00033753848,0.0008518567,0.0021739618,0.025172532,0.078608625],"study_design_scores_gemma":[0.00002717879,0.00018417461,0.7156406,0.00085817627,0.0001066881,0.0009047401,0.24869055,0.0006276363,0.00040229622,0.0009490679,0.03147263,0.00013627604],"about_ca_topic_score_codex":0.93925893,"about_ca_topic_score_gemma":0.9609512,"teacher_disagreement_score":0.060741067,"about_ca_system_score_codex":0.02648967,"about_ca_system_score_gemma":0.05440664,"threshold_uncertainty_score":0.1921969},"labels":[],"label_agreement":null},{"id":"W3186009020","doi":"10.1177/20552173211029674","title":"A retrospective analysis of changes in lymphocyte levels in patients with multiple sclerosis during and after Tecfidera® treatment","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Burnaby Hospital; Fraser Health","funders":"","keywords":"Discontinuation; CD8; Multiple sclerosis; Lymphocyte; Immune system; Medicine; CD4-CD8 Ratio; Immunology; Internal medicine; T cell; Lymphocyte subsets","score_opus":0.10685758854566958,"score_gpt":0.34254754273791105,"score_spread":0.23568995419224148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186009020","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993592,0.00018015434,0.000034104196,0.000007104444,0.0000019340625,0.0000064452834,0.000233842,0.0000019328786,0.00017531938],"genre_scores_gemma":[0.9994537,0.00007048012,0.000038419425,0.0000118112,0.000004404529,0.0000075210064,0.00034319918,0.0000011457818,0.00006935674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946254,0.0000961179,0.000083193736,0.00013811336,0.00012653222,0.000093500224],"domain_scores_gemma":[0.9986305,0.00023595495,0.0005903998,0.000107388834,0.00025077877,0.00018499397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049563963,0.00018843974,0.00038197933,0.0010262175,0.00045674917,0.000461667,0.00023937057,0.00033438313,0.0006883948],"category_scores_gemma":[0.0015701985,0.00020381837,0.0003262883,0.0009917822,0.00023718753,0.00032168423,0.00026647304,0.0003509483,0.00019340319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001644286,0.000020039568,0.9984635,0.0000063280854,0.000017813534,0.00013209121,0.00005385905,0.00001164326,0.00021041732,0.0000025586462,0.000030714575,0.000886616],"study_design_scores_gemma":[0.0000047909857,0.00021332214,0.99863833,0.0000032884934,0.000022071408,0.00064522104,0.0001243009,0.00004533655,0.0001269101,0.0000037044363,0.00016993012,0.0000028649426],"about_ca_topic_score_codex":0.0067943456,"about_ca_topic_score_gemma":0.0057118214,"teacher_disagreement_score":0.0067943456,"about_ca_system_score_codex":0.00047916477,"about_ca_system_score_gemma":0.00038392117,"threshold_uncertainty_score":0.013509572},"labels":[],"label_agreement":null},{"id":"W3186349681","doi":"10.1177/20552173211024298","title":"Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Cladribine; Multiple sclerosis; Adverse effect; Medicine; Phase (matter); Pharmacology; Internal medicine; Psychiatry; Chemistry","score_opus":0.3857309654780424,"score_gpt":0.4771650838811986,"score_spread":0.09143411840315618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186349681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982251,0.011482438,0.0012460806,0.00040367254,0.00011765043,0.0028359864,0.00060361426,0.00007212659,0.0009874282],"genre_scores_gemma":[0.9919465,0.0018386403,0.0022551375,0.00032845914,0.00007555857,0.0026617742,0.0005842928,0.0000115417215,0.0002980865],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9921625,0.0058568493,0.0008184118,0.00035385563,0.0005638286,0.00024445477],"domain_scores_gemma":[0.9878106,0.006494076,0.0034595737,0.00062131765,0.0008361756,0.0007782887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018427648,0.0006537878,0.0019475502,0.00042121336,0.0004925599,0.0008376745,0.00040224282,0.00089217984,0.0018847496],"category_scores_gemma":[0.016615158,0.00045238444,0.0024668316,0.00052507356,0.0004460629,0.00071902404,0.0003834855,0.001411039,0.00015510773],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7739463,0.0063941055,0.044011723,0.0044364673,0.007993932,0.00037669836,0.0006924092,0.0021321368,0.02285978,0.00031741534,0.0021082866,0.13473082],"study_design_scores_gemma":[0.4836748,0.26507697,0.23010445,0.00056188455,0.005060007,0.00092387735,0.00017798616,0.00328488,0.0055252165,0.00043599316,0.0050542126,0.00011970824],"about_ca_topic_score_codex":0.0004861817,"about_ca_topic_score_gemma":0.0021129327,"teacher_disagreement_score":0.018427648,"about_ca_system_score_codex":0.00072587305,"about_ca_system_score_gemma":0.0012824459,"threshold_uncertainty_score":0.09745592},"labels":[],"label_agreement":null},{"id":"W3186380202","doi":"10.1177/20552173211032313","title":"The road to conception for women with multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of British Columbia","funders":"","keywords":"Pregnancy; Multiple sclerosis; Prospective cohort study; Medicine; Psychiatry; Surgery","score_opus":0.1923408582830517,"score_gpt":0.38959881789121203,"score_spread":0.19725795960816034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186380202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8984843,0.029005969,0.0008655206,0.041126132,0.00054747757,0.00034358265,0.0017792743,0.000051946543,0.027795874],"genre_scores_gemma":[0.98896307,0.005931998,0.0007977022,0.0020615335,0.00014553292,0.000101538004,0.0002865895,0.0000089402665,0.0017032145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998083,0.00095931196,0.000077389996,0.00014836527,0.000323868,0.00040817208],"domain_scores_gemma":[0.99485576,0.0023960008,0.0014646186,0.00020421659,0.00034736854,0.00073194306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00293324,0.00015325303,0.00025868873,0.0005304713,0.002188111,0.0013774754,0.0004786966,0.0011821114,0.0064948136],"category_scores_gemma":[0.02092609,0.00028391613,0.00043081882,0.0006301561,0.0007906977,0.0011531261,0.0010291493,0.0018319173,0.00052843685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015990824,0.00029529966,0.8629621,0.0004178621,0.000088121684,0.0007285569,0.0043506613,0.00011045728,0.00017049648,0.0023009377,0.008749728,0.11822659],"study_design_scores_gemma":[0.00022353909,0.0015409347,0.9281194,0.0013657276,0.00027855783,0.0047119604,0.017344834,0.00041853066,0.0004729579,0.005283906,0.040144876,0.0000946441],"about_ca_topic_score_codex":0.029785419,"about_ca_topic_score_gemma":0.031612262,"teacher_disagreement_score":0.029785419,"about_ca_system_score_codex":0.0013534242,"about_ca_system_score_gemma":0.0042121047,"threshold_uncertainty_score":0.05922413},"labels":[],"label_agreement":null},{"id":"W3186595272","doi":"10.1177/20552173211029966","title":"Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital; University of British Columbia","funders":"VGH and UBC Hospital Foundation","keywords":"Thematic analysis; Medicine; Relapsing remitting; Decision aids; Qualitative research; Multiple sclerosis; Psychology; Alternative medicine; Psychiatry; Pathology","score_opus":0.3561606465641006,"score_gpt":0.4171070059915418,"score_spread":0.0609463594274412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186595272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905207,0.00009024505,0.0027856145,0.0012547453,0.00006295351,0.0018601571,0.00017295474,0.0000911836,0.0031614345],"genre_scores_gemma":[0.9659525,0.00015105073,0.029982133,0.0004387055,0.000026512187,0.0024440296,0.00013151704,0.0000133854355,0.0008600875],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98417455,0.013351516,0.0007057238,0.00038883925,0.00087279204,0.0005066562],"domain_scores_gemma":[0.9495155,0.0433823,0.0012748224,0.0010211831,0.0022468427,0.0025593126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017365003,0.00057847425,0.00037601043,0.00046012562,0.0012330414,0.0016051916,0.0012756768,0.00083617755,0.00401436],"category_scores_gemma":[0.048944026,0.00024614835,0.00059844175,0.00043201807,0.00092967454,0.0012405821,0.0021092433,0.0010690449,0.0003515524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007189218,0.026484115,0.11278213,0.0034497797,0.00019420443,0.0025597522,0.20280412,0.0032383243,0.0057452377,0.0017877453,0.006219976,0.6275454],"study_design_scores_gemma":[0.011623191,0.16290331,0.24867998,0.0028032225,0.001201422,0.004817559,0.3995852,0.033613194,0.036111128,0.0072148386,0.09070953,0.0007374328],"about_ca_topic_score_codex":0.0010015974,"about_ca_topic_score_gemma":0.0019058255,"teacher_disagreement_score":0.017365003,"about_ca_system_score_codex":0.0012743894,"about_ca_system_score_gemma":0.0033079814,"threshold_uncertainty_score":0.091836035},"labels":[],"label_agreement":null},{"id":"W3198306866","doi":"10.1177/20552173211038030","title":"Research interrupted: The impact of the COVID-19 pandemic on multiple sclerosis research in the field of rehabilitation and quality of life","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Memorial University of Newfoundland","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Rehabilitation; Wilcoxon signed-rank test; Quality of life (healthcare); 2019-20 coronavirus outbreak; Psychology; Multiple sclerosis; Medicine; Gerontology; Nursing; Physical therapy; Disease; Psychiatry; Pathology","score_opus":0.6494420521584078,"score_gpt":0.5775456845627955,"score_spread":0.07189636759561224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198306866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8390273,0.020476818,0.0029472462,0.10844456,0.0027272573,0.0004347194,0.0017403881,0.00010291245,0.024098877],"genre_scores_gemma":[0.9717776,0.006549025,0.0029541792,0.013900588,0.00085896696,0.00039240243,0.00052060164,0.000050639457,0.0029959353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95588404,0.03011514,0.004386233,0.0013407997,0.006104212,0.002169574],"domain_scores_gemma":[0.70627314,0.18073733,0.054858636,0.013003358,0.02930082,0.015826741],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07171264,0.00023372854,0.00045266846,0.0010713959,0.0021956635,0.003628952,0.0010040685,0.0019203989,0.01021197],"category_scores_gemma":[0.16194707,0.00031226792,0.0007863977,0.0020198817,0.0019497279,0.0031356076,0.0033973535,0.0020851733,0.00089286646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014907443,0.00038770525,0.61783874,0.008887671,0.00043025377,0.0010749699,0.056525193,0.00034948706,0.0036625178,0.005582735,0.031266943,0.272503],"study_design_scores_gemma":[0.00012765695,0.0016573113,0.7967479,0.007055914,0.0002776867,0.0011397565,0.09030691,0.00030487345,0.001330551,0.0017812874,0.09917316,0.000097082586],"about_ca_topic_score_codex":0.0056520347,"about_ca_topic_score_gemma":0.009317624,"teacher_disagreement_score":0.9282874,"about_ca_system_score_codex":0.0032421427,"about_ca_system_score_gemma":0.011642141,"threshold_uncertainty_score":0.37925726},"labels":[],"label_agreement":null},{"id":"W4200041687","doi":"10.1177/20552173211065730","title":"Season of birth is associated with multiple sclerosis and disease severity","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Vetenskapsrådet; Hjärnfonden; Horizon 2020 Framework Programme; Knut och Alice Wallenbergs Stiftelse; Multiple Sclerosis Society of Canada","keywords":"Season of birth; Medicine; Multiple sclerosis; Incidence (geometry); Vitamin D and neurology; Breastfeeding; Population; Demography; Pediatrics; Cohort study; Disease; Cohort; Logistic regression; Internal medicine; Environmental health; Immunology","score_opus":0.15325505423640565,"score_gpt":0.35890842618771174,"score_spread":0.2056533719513061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200041687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833494,0.00083162036,0.00014050795,0.00007330505,0.00002102489,0.000003090236,0.00024934136,0.000008084633,0.00033802923],"genre_scores_gemma":[0.99910575,0.00032601116,0.00012859673,0.000010938313,0.000014787544,0.000002738245,0.00019867293,0.000004671783,0.0002078343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972993,0.000098479184,0.000029935196,0.000058298705,0.000040977287,0.00004237419],"domain_scores_gemma":[0.99750525,0.00047790873,0.001326622,0.00012625866,0.00016414051,0.00039995863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049991655,0.00019098955,0.000241036,0.00053160515,0.0002637219,0.0004590223,0.00020038398,0.00023167381,0.002228063],"category_scores_gemma":[0.002577733,0.0001587762,0.00046093643,0.00056030956,0.00020179938,0.00013506127,0.00029048164,0.00027214398,0.0001551595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000263102,0.000009345432,0.9978326,0.000012005518,0.0000794386,0.00006230238,0.000046814137,0.000020264673,0.0005361095,0.000015096801,0.000060695224,0.0010621987],"study_design_scores_gemma":[0.0000021049423,0.000034786128,0.99960893,0.0000046074883,0.000023249302,0.00013788116,0.000022630045,0.000032306085,0.00003706239,0.000010002805,0.00008547425,9.500756e-7],"about_ca_topic_score_codex":0.005312681,"about_ca_topic_score_gemma":0.0047082943,"teacher_disagreement_score":0.005312681,"about_ca_system_score_codex":0.00015613131,"about_ca_system_score_gemma":0.00025897397,"threshold_uncertainty_score":0.010563493},"labels":[],"label_agreement":null},{"id":"W4200169784","doi":"10.1177/20552173211051855","title":"Multiple Sclerosis International Federation guideline methodology for off-label treatments for multiple sclerosis","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Guideline; Checklist; Grading (engineering); Transparency (behavior); Medicine; Judgement; Population; Medical education; Public relations; Psychology; Political science; Environmental health; Engineering; Pathology","score_opus":0.6834472202916444,"score_gpt":0.5261637888695437,"score_spread":0.15728343142210066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200169784","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056453324,0.045687374,0.32261404,0.22104466,0.021495553,0.24095114,0.028997619,0.0021536457,0.111410685],"genre_scores_gemma":[0.011135809,0.01422337,0.83565986,0.017233312,0.00096136297,0.09961107,0.011506524,0.00031524853,0.009353319],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.7540492,0.13052215,0.07309943,0.003879421,0.035444796,0.0030050515],"domain_scores_gemma":[0.71677524,0.07726579,0.03207025,0.013544548,0.15571524,0.0046289335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15693358,0.0021399395,0.0027395918,0.012739579,0.0032093602,0.0074948585,0.01123034,0.011355048,0.006424744],"category_scores_gemma":[0.3134084,0.0019695433,0.008217186,0.011752717,0.003942767,0.004200973,0.007030532,0.0121254055,0.0064603123],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020773256,0.00034517286,0.002779399,0.028191734,0.0004650147,0.00059678894,0.006405237,0.0018896243,0.0014927731,0.033605404,0.6341809,0.2898403],"study_design_scores_gemma":[0.0006559336,0.0002691923,0.0054319305,0.075464815,0.0008301113,0.00071688346,0.0017188747,0.0019253364,0.0016634098,0.02818215,0.8828813,0.00026003845],"about_ca_topic_score_codex":0.024539208,"about_ca_topic_score_gemma":0.04014017,"teacher_disagreement_score":0.15693358,"about_ca_system_score_codex":0.011878319,"about_ca_system_score_gemma":0.07750095,"threshold_uncertainty_score":0.829954},"labels":[],"label_agreement":null},{"id":"W4205295256","doi":"10.1177/20552173221074296","title":"Development of an indicator of smoking status for people with multiple sclerosis in administrative data","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"Research Manitoba","keywords":"Confounding; Medicine; Predictive value; Pulmonary disease; Disease; Environmental health; Smoking cessation; Tobacco control; Public health; Internal medicine; Pathology","score_opus":0.35258671803505,"score_gpt":0.43036655638331683,"score_spread":0.07777983834826685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205295256","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9270884,0.00072421,0.03898076,0.0011412605,0.00013002046,0.0024862713,0.025004387,0.0005203331,0.003924438],"genre_scores_gemma":[0.9438965,0.00018291398,0.044977233,0.00015353713,0.000044712884,0.0013564252,0.009109384,0.00002489905,0.0002545042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9926939,0.0031024625,0.0013125832,0.00074264745,0.001711715,0.00043660618],"domain_scores_gemma":[0.9676436,0.0118176155,0.010459578,0.0024085839,0.006723606,0.0009470227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017812695,0.00069363456,0.00076546805,0.0052233385,0.0007479788,0.0018342608,0.0017945963,0.0008307307,0.0010701892],"category_scores_gemma":[0.043271113,0.0005176105,0.0014490852,0.0040911306,0.00049408793,0.0011738396,0.0014654365,0.0011440363,0.00025102447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008377088,0.00007960897,0.99234325,0.000072187264,0.000103031394,0.00003088128,0.00011406754,0.0005983034,0.00014879328,0.00018724719,0.0006554613,0.0055834474],"study_design_scores_gemma":[0.000047502064,0.00022796514,0.9849223,0.00010070641,0.00016708438,0.00012518458,0.00027266034,0.011212547,0.0008489438,0.00030851774,0.0017432657,0.000023384806],"about_ca_topic_score_codex":0.04064859,"about_ca_topic_score_gemma":0.045006342,"teacher_disagreement_score":0.04064859,"about_ca_system_score_codex":0.002394282,"about_ca_system_score_gemma":0.0048366413,"threshold_uncertainty_score":0.09420371},"labels":[],"label_agreement":null},{"id":"W4205669566","doi":"10.1177/20552173211070760","title":"Cervical Spinal Cord Atrophy can be Accurately Quantified Using Head Images","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada; Multiple Sclerosis Society of Canada","keywords":"Spinal cord; Medicine; Cord; Atrophy; Magnetic resonance imaging; Central nervous system disease; Nuclear medicine; Radiology; Pathology; Internal medicine; Surgery","score_opus":0.514306738036913,"score_gpt":0.5040454166111249,"score_spread":0.010261321425788061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205669566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9394727,0.0072503127,0.029438471,0.00030970544,0.00008413927,0.00027217378,0.0062143896,0.001337867,0.015620282],"genre_scores_gemma":[0.9841628,0.0012117713,0.01207198,0.000085555286,0.00005935908,0.00011179944,0.0011699582,0.000083843224,0.0010430304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909496,0.00015581035,0.00007492814,0.0002287939,0.00037716664,0.000068301044],"domain_scores_gemma":[0.99738187,0.00075820374,0.0006713941,0.00024208019,0.0008295348,0.00011686869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075680163,0.0007533923,0.0004453506,0.0031845386,0.00038415054,0.0012439383,0.0005125835,0.00075555354,0.0040736725],"category_scores_gemma":[0.006118752,0.00034669557,0.00037727068,0.0017700909,0.0005320211,0.00060453854,0.0006204105,0.00028372806,0.0011474524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011010192,0.000043046995,0.72622806,0.0007241638,0.0006974112,0.0005727444,0.0005538913,0.0036454748,0.08600813,0.0004687789,0.0033050175,0.17665231],"study_design_scores_gemma":[0.000009419003,0.000117637595,0.98221695,0.00007668473,0.00010849786,0.00095261517,0.00011728138,0.003464911,0.010702225,0.00032584718,0.0018608579,0.000047053712],"about_ca_topic_score_codex":0.020204991,"about_ca_topic_score_gemma":0.027855868,"teacher_disagreement_score":0.020204991,"about_ca_system_score_codex":0.0007165393,"about_ca_system_score_gemma":0.00050400913,"threshold_uncertainty_score":0.040174782},"labels":[],"label_agreement":null},{"id":"W4212934277","doi":"10.1177/20552173221078834","title":"Quantitative MRI findings indicate diffuse white matter damage in Susac Syndrome","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia","funders":"Multiple Sclerosis Society of Canada","keywords":"White matter; Fractional anisotropy; Corpus callosum; Multiple sclerosis; Diffusion MRI; Myelin; Pathology; Medicine; Effective diffusion coefficient; Nuclear medicine; Magnetic resonance imaging; Internal medicine; Central nervous system; Radiology; Immunology","score_opus":0.0943923739671718,"score_gpt":0.34868010557157597,"score_spread":0.25428773160440415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212934277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99850357,0.0003566181,0.0004748643,0.000024003124,0.0000036611232,0.0000075310736,0.00009459375,0.000032550608,0.00050269515],"genre_scores_gemma":[0.9988127,0.00013821415,0.0007602754,0.000022480623,0.000007433804,0.000006080472,0.00009606969,0.000007445425,0.00014946154],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99981874,0.000025801966,0.00003142093,0.00004552049,0.000055567354,0.00002300495],"domain_scores_gemma":[0.9993037,0.000121758254,0.0003356407,0.000049439066,0.000106041654,0.00008335928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038534217,0.00068416743,0.00024121923,0.0010563979,0.00018701155,0.00023147599,0.00020042677,0.00032482488,0.0029751048],"category_scores_gemma":[0.00091727544,0.0001598223,0.00018405184,0.00037479043,0.00037710727,0.0002227948,0.00021658059,0.00018427659,0.00027549206],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022424546,0.0002098278,0.47741953,0.0004845656,0.00044189513,0.012649591,0.00089408737,0.0003447185,0.47980607,0.00032828114,0.00056132866,0.02461748],"study_design_scores_gemma":[0.000044091525,0.0008634735,0.92778933,0.000047267316,0.00015692326,0.052031703,0.00033776902,0.0006371474,0.01717386,0.00029931753,0.000603197,0.000015948499],"about_ca_topic_score_codex":0.0009568106,"about_ca_topic_score_gemma":0.0011459984,"teacher_disagreement_score":0.0029751048,"about_ca_system_score_codex":0.0001567665,"about_ca_system_score_gemma":0.00013155762,"threshold_uncertainty_score":0.009952724},"labels":[],"label_agreement":null},{"id":"W4225408553","doi":"10.1177/20552173221099181","title":"Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach—perspectives from the International Progressive MS Alliance","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Alliance; Coronavirus disease 2019 (COVID-19); Stakeholder; Discipline; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Political science; Engineering ethics; Public relations; Engineering; Medicine; Virology; Law","score_opus":0.38754284603938016,"score_gpt":0.4547668075435914,"score_spread":0.06722396150421123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225408553","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006872107,0.032410778,0.005962419,0.93799883,0.003575144,0.00011843536,0.00006820435,0.000031737032,0.012962244],"genre_scores_gemma":[0.53923434,0.096303724,0.039724458,0.30831537,0.0068177236,0.0008117446,0.00022821566,0.000083653584,0.008480814],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9521379,0.038462866,0.001118292,0.0015617827,0.0033145528,0.0034047225],"domain_scores_gemma":[0.9434942,0.029968183,0.0027608273,0.0021039383,0.008684422,0.012988432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08339542,0.0007936391,0.0009818049,0.0014726466,0.0064307773,0.013682134,0.0022400783,0.009536811,0.0035448626],"category_scores_gemma":[0.027968971,0.00032817383,0.0013105746,0.0011914304,0.011294228,0.012056772,0.01238091,0.012829593,0.0005862053],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003493632,0.00064676127,0.01374907,0.004807342,0.0003640406,0.0022189547,0.09366903,0.0015587466,0.0059233643,0.41368988,0.22673078,0.2362927],"study_design_scores_gemma":[0.00009665608,0.0005436285,0.0064728744,0.007177608,0.00017487672,0.0013598136,0.11401377,0.00095749274,0.0018250964,0.29539552,0.57184327,0.000139386],"about_ca_topic_score_codex":0.0043326747,"about_ca_topic_score_gemma":0.007466242,"teacher_disagreement_score":0.08339542,"about_ca_system_score_codex":0.0069038454,"about_ca_system_score_gemma":0.03921613,"threshold_uncertainty_score":0.44104242},"labels":[],"label_agreement":null},{"id":"W4280501079","doi":"10.1177/20552173221086662","title":"Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: A pilot randomized controlled trial","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; St Joseph's Health Care; Lawson Health Research Institute; London Health Sciences Centre; Western University","funders":"London Health Sciences Foundation","keywords":"Medicine; Intestinal permeability; Multiple sclerosis; Gut flora; Gastroenterology; Internal medicine; Randomized controlled trial; Transplantation; Feces; Fecal bacteriotherapy; Immunology; Biology; Antibiotics","score_opus":0.044974120161359966,"score_gpt":0.2874829487925395,"score_spread":0.24250882863117953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280501079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858123,0.006211468,0.0005473447,0.00096823444,0.0007140219,0.0042948737,0.0005045945,0.00010795601,0.000839167],"genre_scores_gemma":[0.98840386,0.0025040885,0.0011804417,0.0008993019,0.0006085143,0.005105009,0.00035127794,0.000013503506,0.000933991],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990188,0.00053983106,0.000089175264,0.00015071544,0.00006787397,0.00013353094],"domain_scores_gemma":[0.9981704,0.0005493623,0.0004915352,0.00013219421,0.00011122699,0.00054528215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020178296,0.0013136651,0.0035051939,0.0004668249,0.00073949614,0.0011055539,0.00069684634,0.002233915,0.0052854386],"category_scores_gemma":[0.002680491,0.0004947607,0.0022463803,0.0005929111,0.0013564238,0.0010941385,0.00053286785,0.0023851003,0.00048593522],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98531497,0.0047263973,0.00041702235,0.00050143985,0.00075509935,0.000040073297,0.000024903013,0.00007834807,0.00081536104,0.000033070613,0.0001983811,0.007094926],"study_design_scores_gemma":[0.91000783,0.08736515,0.0015281135,0.00004617803,0.00044513156,0.000023224864,0.000017400826,0.0001546271,0.00014830306,0.00006445042,0.00019182437,0.000007757279],"about_ca_topic_score_codex":0.00075558195,"about_ca_topic_score_gemma":0.0013503586,"teacher_disagreement_score":0.0052854386,"about_ca_system_score_codex":0.0006101339,"about_ca_system_score_gemma":0.0012451806,"threshold_uncertainty_score":0.017681539},"labels":[],"label_agreement":null},{"id":"W4281294196","doi":"10.1177/20552173221102067","title":"Attitudes toward coronavirus disease 2019 vaccination in people with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Vaccination; Medicine; Influenza vaccine; Multiple sclerosis; Adverse effect; Logistic regression; Population; Disease; Coronavirus disease 2019 (COVID-19); Demography; Environmental health; Immunology; Internal medicine; Infectious disease (medical specialty)","score_opus":0.21049615459634044,"score_gpt":0.4106501778545134,"score_spread":0.20015402325817297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281294196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980977,0.00020182131,0.000029323117,0.0005029139,0.000014659175,0.000009533241,0.00009850178,0.0000019558338,0.0010436208],"genre_scores_gemma":[0.99941397,0.00012708477,0.000027696507,0.00016407158,0.000017659451,0.00000659642,0.00005175316,4.987083e-7,0.0001906939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994018,0.0002165357,0.00006625092,0.00006152357,0.00015375928,0.00010009421],"domain_scores_gemma":[0.99773103,0.00040254058,0.0012133226,0.000044753822,0.0002571971,0.0003512133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012801596,0.00014689866,0.00018609795,0.00066120294,0.00054451445,0.000640715,0.00016289491,0.0005903097,0.0025206723],"category_scores_gemma":[0.004966113,0.0001734778,0.00048316558,0.00048305665,0.0003209252,0.000618172,0.00053691573,0.00063703395,0.00033813913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034958965,0.00006691551,0.9950512,0.00002627328,0.000029817358,0.00004921953,0.0014086644,0.000030612115,0.00008339294,0.000015718098,0.0002093076,0.0029938417],"study_design_scores_gemma":[0.000006455234,0.00018791753,0.9960829,0.00005463697,0.000020855266,0.00015289115,0.0028059843,0.00015207854,0.00003635423,0.0000313594,0.00046332044,0.0000052593514],"about_ca_topic_score_codex":0.012880997,"about_ca_topic_score_gemma":0.011544011,"teacher_disagreement_score":0.012880997,"about_ca_system_score_codex":0.00035876004,"about_ca_system_score_gemma":0.00033375953,"threshold_uncertainty_score":0.025612056},"labels":[],"label_agreement":null},{"id":"W4282969109","doi":"10.1177/20552173221104918","title":"Peripartum disease activity in moderately and severely disabled women with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"Barts Charity","keywords":"Multiple sclerosis; Disease; Medicine; Physical medicine and rehabilitation; Physical therapy; Gerontology; Psychology; Internal medicine; Psychiatry","score_opus":0.16134619391204033,"score_gpt":0.35036787254433577,"score_spread":0.18902167863229544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282969109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923,0.0004570852,0.00002789984,0.000023693714,0.000002645826,0.0000037489365,0.00006782037,0.0000011343432,0.00018593979],"genre_scores_gemma":[0.99965763,0.00016812485,0.000037810147,0.000011530728,0.0000046852083,0.0000048191805,0.000057944686,6.4918123e-7,0.00005685131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958044,0.00017616664,0.000039739705,0.000066530025,0.00007215261,0.00006480041],"domain_scores_gemma":[0.9984199,0.00041180983,0.00084275694,0.0000912257,0.0000694472,0.00016488117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073187955,0.00019296499,0.00023108546,0.0004971533,0.00033635407,0.0003922087,0.00022382254,0.00034505234,0.00064742233],"category_scores_gemma":[0.004157004,0.00021105625,0.00020802605,0.0005029258,0.00023222537,0.00024111001,0.00033762568,0.00038978737,0.00013998897],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019235811,0.000016933527,0.9982608,0.0000063428342,0.0000136140525,0.00012579268,0.000075256066,0.000011164011,0.00010971843,0.000005990089,0.000020838748,0.0011612069],"study_design_scores_gemma":[0.0000039137194,0.00014842073,0.9989618,0.00000669652,0.00001465521,0.00060923886,0.00009152835,0.000038737806,0.000043175103,0.000009566805,0.000070489856,0.0000018071321],"about_ca_topic_score_codex":0.0025730638,"about_ca_topic_score_gemma":0.002693608,"teacher_disagreement_score":0.0025730638,"about_ca_system_score_codex":0.00020824019,"about_ca_system_score_gemma":0.00022581754,"threshold_uncertainty_score":0.0051161647},"labels":[],"label_agreement":null},{"id":"W4284675099","doi":"10.1177/20552173221111761","title":"Assessing proprioceptive acuity in people with multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Multiple Sclerosis Society of Canada; University of Ottawa","keywords":"Proprioception; Multiple sclerosis; Physical medicine and rehabilitation; Psychology; Audiology; Medicine; Psychiatry","score_opus":0.18543735322393964,"score_gpt":0.41599452518680363,"score_spread":0.230557171962864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4284675099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989089,0.0001929546,0.000061568506,0.00003458067,0.0000037208404,0.000020448391,0.00010796741,0.0000052103405,0.00066466036],"genre_scores_gemma":[0.99939203,0.000114121605,0.00015391095,0.00003198906,0.0000045558527,0.000024025052,0.00009124628,7.042116e-7,0.00018741743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956125,0.000086924905,0.00009427334,0.000057808404,0.00013699761,0.00006268075],"domain_scores_gemma":[0.99855345,0.00022686072,0.0006549475,0.0000447423,0.00033104155,0.00018889364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078141893,0.00031880883,0.0004201446,0.0013612119,0.0005181632,0.0005357346,0.00022718673,0.00054087647,0.0021356377],"category_scores_gemma":[0.0032328162,0.00013765016,0.00036111465,0.00074266776,0.00025762664,0.00052991044,0.00070897926,0.0003777285,0.00056664075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016245991,0.0001613491,0.98684955,0.00006831326,0.00003556417,0.00009075827,0.00088338874,0.00004173788,0.0007146467,0.000010063202,0.00015755571,0.0108246915],"study_design_scores_gemma":[0.000010009043,0.00052054407,0.9976687,0.00001906342,0.000016648197,0.00043618964,0.00081766915,0.00008322495,0.00020778885,0.000041429557,0.00017414987,0.0000046406535],"about_ca_topic_score_codex":0.0022790963,"about_ca_topic_score_gemma":0.0038260047,"teacher_disagreement_score":0.0022790963,"about_ca_system_score_codex":0.00021177428,"about_ca_system_score_gemma":0.00025308735,"threshold_uncertainty_score":0.0071443915},"labels":[],"label_agreement":null},{"id":"W4306880421","doi":"10.1177/20552173221128170","title":"Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review","year":2022,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Autoimmune Neurological Disorders and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Neuromyelitis optica; Autoantibody; Myelin oligodendrocyte glycoprotein; Immunology; Multiple sclerosis; Autoimmunity; Optic neuritis; Disease; Pathology; Antibody; Dermatology; Experimental autoimmune encephalomyelitis","score_opus":0.11078807318113018,"score_gpt":0.37206325246990163,"score_spread":0.2612751792887714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306880421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011890489,0.9976653,0.00008900563,0.00021484886,0.00008192103,0.00013361468,0.0004369974,0.0000063276107,0.00018304776],"genre_scores_gemma":[0.020342976,0.97757363,0.00039765297,0.000633245,0.00012345224,0.00043724792,0.0003771837,0.0000055695327,0.000109059525],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99537486,0.0012350469,0.0019591167,0.00048256628,0.0007407794,0.00020758847],"domain_scores_gemma":[0.9825581,0.011556073,0.003613474,0.00025524624,0.0017789094,0.00023836354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004632771,0.0014526519,0.007864412,0.010578047,0.0006399128,0.0019658857,0.0014325115,0.001968226,0.004267256],"category_scores_gemma":[0.020733202,0.00088896934,0.008347182,0.012356439,0.00062757795,0.0016812186,0.0013114786,0.0008723422,0.00028231493],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017317674,0.000009760948,0.0018481517,0.9661738,0.013393567,0.00014758276,0.00012305264,0.00006448909,0.00012687377,0.00012280351,0.0014169458,0.016399845],"study_design_scores_gemma":[0.00029045672,0.00021249618,0.011086034,0.7900672,0.18132804,0.00096108526,0.00034065224,0.00012539559,0.00016450745,0.00032858644,0.015041478,0.000054196935],"about_ca_topic_score_codex":0.009975929,"about_ca_topic_score_gemma":0.027280046,"teacher_disagreement_score":0.010578047,"about_ca_system_score_codex":0.002479823,"about_ca_system_score_gemma":0.008321227,"threshold_uncertainty_score":0.024500728},"labels":[],"label_agreement":null},{"id":"W4306954832","doi":"10.1177/20552173221132170","title":"Quantitative spinal cord MRI and sexual dysfunction in multiple sclerosis","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Fractional anisotropy; Medicine; Multiple sclerosis; Anxiety; Magnetic resonance imaging; Depression (economics); Internal medicine; Diffusion MRI; Spinal cord; Mood; Physical therapy; Psychiatry; Radiology","score_opus":0.31429161236454284,"score_gpt":0.415623184933406,"score_spread":0.10133157256886316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306954832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973024,0.0016299993,0.00019176702,0.000049269056,0.0000050417257,0.000014366212,0.0001587553,0.0000070745723,0.0006413731],"genre_scores_gemma":[0.9995378,0.00016727312,0.00013046365,0.00001719092,0.000008209681,0.000005633265,0.00006109911,8.151028e-7,0.00007150046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997695,0.000088492496,0.000035063287,0.00003207453,0.000055463923,0.000019486142],"domain_scores_gemma":[0.9985649,0.00042665622,0.0006780876,0.000061499144,0.00014591099,0.00012303259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006417261,0.00026060155,0.00027320805,0.00092711195,0.00017184463,0.00033371118,0.00017897437,0.00023039358,0.0022379095],"category_scores_gemma":[0.0025873245,0.00009213234,0.0001749901,0.0005600255,0.0003762643,0.0002465011,0.0002919615,0.00024783303,0.00013982688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005671458,0.00010440644,0.9764075,0.00023920854,0.00012493644,0.0009042447,0.00021110057,0.00013147795,0.0074871285,0.000058034006,0.00011187372,0.013652914],"study_design_scores_gemma":[0.000008319549,0.00031526983,0.99560636,0.000026849431,0.000024345592,0.0030249169,0.00012386266,0.00014694795,0.00050519645,0.0000941682,0.00012037212,0.0000033361716],"about_ca_topic_score_codex":0.00073630153,"about_ca_topic_score_gemma":0.0008200934,"teacher_disagreement_score":0.0022379095,"about_ca_system_score_codex":0.00016877598,"about_ca_system_score_gemma":0.00014344275,"threshold_uncertainty_score":0.007486582},"labels":[],"label_agreement":null},{"id":"W4309322144","doi":"10.1177/20552173221135888","title":"Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Clinique Neuro-Outaouais","funders":"Sanofi","keywords":"Medicine; Multiple sclerosis; Observational study; Clinical endpoint; Adverse effect; Patient satisfaction; Quality of life (healthcare); Physical therapy; Internal medicine; Expanded Disability Status Scale; Clinical trial; Surgery; Psychiatry","score_opus":0.1904584400154137,"score_gpt":0.3710858660872564,"score_spread":0.1806274260718427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309322144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984749,0.00034143307,0.00012545948,0.00007868323,0.000007171795,0.000044076092,0.0005340295,0.0000054200796,0.00038882127],"genre_scores_gemma":[0.99879515,0.00011031303,0.0001365989,0.000079567864,0.000018447274,0.00005429453,0.0006612419,0.0000023864955,0.00014187902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972662,0.0018635264,0.00022844282,0.00016504317,0.00035073142,0.00012612372],"domain_scores_gemma":[0.9925816,0.0017822176,0.003838929,0.00028704535,0.0006390452,0.0008710809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039674244,0.0002991605,0.0005122513,0.000417942,0.00021362382,0.0007549346,0.00027046754,0.00045516228,0.0007368641],"category_scores_gemma":[0.0063889353,0.000119445285,0.00092904276,0.00064207875,0.00026135522,0.0004128298,0.000518056,0.00056360307,0.00021794553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061388444,0.000715748,0.9784517,0.00008872579,0.0007176478,0.00007328738,0.00030200346,0.00031252572,0.00046345787,0.000033801258,0.00055779365,0.0121446],"study_design_scores_gemma":[0.0005287552,0.0031325007,0.99365246,0.00001530214,0.00025261624,0.00023617398,0.00015882879,0.0009791254,0.00018234157,0.000033186603,0.00081150635,0.000017163755],"about_ca_topic_score_codex":0.00063911075,"about_ca_topic_score_gemma":0.00066236,"teacher_disagreement_score":0.0039674244,"about_ca_system_score_codex":0.0002593936,"about_ca_system_score_gemma":0.0002149316,"threshold_uncertainty_score":0.020981967},"labels":[],"label_agreement":null},{"id":"W4310598601","doi":"10.1177/20552173221138935","title":"Profiles of resilience in multiple sclerosis family care-partners: A Canadian cross-sectional study","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; University of Ottawa","funders":"","keywords":"Psychological resilience; Context (archaeology); Multilevel model; Psychology; Social support; Population; Multiple sclerosis; Expanded Disability Status Scale; Cross-sectional study; Clinical psychology; Medicine; Gerontology; Psychiatry; Social psychology; Environmental health; Geography","score_opus":0.26364523504316434,"score_gpt":0.42362612704434643,"score_spread":0.1599808920011821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310598601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982679,0.00033356575,0.00005153615,0.000087965345,0.0000033822882,0.000042853797,0.00061227375,0.000002633674,0.0005980212],"genre_scores_gemma":[0.99903786,0.0003280342,0.00009934445,0.00003870722,0.0000018043593,0.000026065902,0.00028721333,0.000001576058,0.00017940145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999246,0.00008629018,0.00006254206,0.0001466779,0.00022838698,0.00023019231],"domain_scores_gemma":[0.9982101,0.00010915306,0.00047101916,0.00008482288,0.0005319911,0.0005929178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013120439,0.00034507617,0.00047552603,0.0013738385,0.0037768465,0.001158143,0.00075997255,0.00055311545,0.0022858721],"category_scores_gemma":[0.0036094359,0.00038429245,0.0006122067,0.0028096067,0.00062056485,0.0007196636,0.0014919185,0.00077456975,0.000263606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036723206,0.000039984614,0.9955148,0.000019917812,0.000023350083,0.000087560176,0.0020392018,0.000015937303,0.00006422648,0.000024652913,0.00017870539,0.0019550272],"study_design_scores_gemma":[0.000004840865,0.000047003276,0.9964393,0.000029783587,0.000017235363,0.00014675116,0.0028648279,0.0000640129,0.000019757636,0.00001873543,0.0003383053,0.000009384325],"about_ca_topic_score_codex":0.9176387,"about_ca_topic_score_gemma":0.9376311,"teacher_disagreement_score":0.08236128,"about_ca_system_score_codex":0.008046056,"about_ca_system_score_gemma":0.0075261043,"threshold_uncertainty_score":0.16569257},"labels":[],"label_agreement":null},{"id":"W4311822595","doi":"10.1177/20552173221144226","title":"Assessing care-related regret among nurses specialized in multiple sclerosis: A psychometric analysis of a new assessment battery","year":2022,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Roche España","keywords":"Regret; Reliability (semiconductor); Scale (ratio); Psychology; Multiple sclerosis; Clinical psychology; Applied psychology; Psychiatry; Statistics; Mathematics","score_opus":0.24620015966906691,"score_gpt":0.43635697319494043,"score_spread":0.19015681352587352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311822595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777067,0.000080758466,0.0007149916,0.000045407967,0.000018076844,0.0003704656,0.00019766352,0.000013896647,0.00078809005],"genre_scores_gemma":[0.9924843,0.00024912838,0.0037794576,0.00009779015,0.000027629341,0.0013088146,0.0011214706,0.0000114495915,0.000920051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972582,0.00093950704,0.00037944838,0.00015692483,0.0011160609,0.000149854],"domain_scores_gemma":[0.9888587,0.0059926845,0.0023149536,0.0006257782,0.0016387322,0.00056907267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005736937,0.0005025079,0.0006770539,0.00091399293,0.00036516436,0.0006506094,0.0005208637,0.0005104844,0.001217441],"category_scores_gemma":[0.016766103,0.00029556543,0.0010518883,0.00050839974,0.0003801874,0.0006937691,0.0011805923,0.0007456651,0.00034412162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019976643,0.0021452943,0.8942787,0.0001749677,0.00038398796,0.00015037801,0.0015965183,0.0013991838,0.0016953269,0.0001135743,0.0009805859,0.095083795],"study_design_scores_gemma":[0.0001691371,0.0032956116,0.9909189,0.000057453653,0.000092622315,0.00025738997,0.00054082874,0.002753996,0.00075935625,0.00014418043,0.0009748905,0.000035714533],"about_ca_topic_score_codex":0.0013830945,"about_ca_topic_score_gemma":0.002177563,"teacher_disagreement_score":0.005736937,"about_ca_system_score_codex":0.00063500146,"about_ca_system_score_gemma":0.0008553528,"threshold_uncertainty_score":0.030340135},"labels":[],"label_agreement":null},{"id":"W4313437367","doi":"10.1177/20552173221142741","title":"Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Bayer HealthCare; Sanofi","keywords":"Medicine; Alemtuzumab; Multiple sclerosis; Thyroid; Endocrine disease; Adverse effect; Graves' disease; Internal medicine; Anti-thyroid autoantibodies; Pediatrics; Endocrine system; Immunology; Hormone; Autoantibody; Antibody","score_opus":0.1679481370235735,"score_gpt":0.3896133738312529,"score_spread":0.22166523680767938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313437367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98507696,0.012799999,0.0000676337,0.00019221717,0.000020149595,0.000055179597,0.00082433695,0.0000024829953,0.00096091133],"genre_scores_gemma":[0.9973821,0.0011873365,0.000099236284,0.00011527429,0.000065555716,0.000045703986,0.0010187752,0.000001427937,0.000084676736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995676,0.0019598186,0.001004796,0.00039892338,0.0007010871,0.00025938865],"domain_scores_gemma":[0.98614776,0.00350004,0.0076856865,0.00054281275,0.0011786865,0.0009450189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006982785,0.0002777533,0.00068206334,0.0019265127,0.00048074886,0.00096707954,0.00049964245,0.0005125082,0.0008006678],"category_scores_gemma":[0.011313712,0.00015730255,0.0012658234,0.0024888488,0.0003303807,0.0007468683,0.00093485706,0.00047996148,0.00007963336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022805275,0.000069004745,0.9901571,0.00022195124,0.0012547998,0.00010106147,0.00017717482,0.0000811584,0.00013221099,0.00007408369,0.00032113408,0.005129827],"study_design_scores_gemma":[0.0004126661,0.001023979,0.9951916,0.00015155101,0.0010205421,0.00044606996,0.00019020398,0.00008610183,0.00013368411,0.00008273142,0.0012480508,0.000012845534],"about_ca_topic_score_codex":0.002268387,"about_ca_topic_score_gemma":0.003321337,"teacher_disagreement_score":0.006982785,"about_ca_system_score_codex":0.0006250055,"about_ca_system_score_gemma":0.0005563688,"threshold_uncertainty_score":0.03692895},"labels":[],"label_agreement":null},{"id":"W4313648494","doi":"10.1177/20552173221143398","title":"Lower corticospinal excitability and greater fatigue among people with multiple sclerosis experiencing pain","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Canada Foundation for Innovation","keywords":"Transcranial magnetic stimulation; Physical medicine and rehabilitation; Physical therapy; Mood; Medicine; Neuromodulation; Visual analogue scale; Quality of life (healthcare); Psychology; Stimulation; Psychiatry; Internal medicine","score_opus":0.18964242464001752,"score_gpt":0.3643150694069121,"score_spread":0.1746726447668946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313648494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878687,0.00063260767,0.00004029767,0.00008014799,0.0000028303014,0.0000074314707,0.00011102049,0.000002085487,0.00033668443],"genre_scores_gemma":[0.99959,0.00019272632,0.000045730874,0.00002743435,0.000007660682,0.000006842385,0.00004963353,3.4459512e-7,0.00007967585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998259,0.000050991737,0.000024196868,0.00003155114,0.000041904717,0.00002540312],"domain_scores_gemma":[0.99921477,0.0001830136,0.00044133308,0.000021461146,0.000066823326,0.00007259028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037058457,0.0001502294,0.00024014893,0.00044958902,0.00027041676,0.00031726825,0.00012857017,0.00030568358,0.0032801179],"category_scores_gemma":[0.0018490102,0.000094416144,0.00020151923,0.0004520585,0.00015889737,0.00024083085,0.00023345371,0.00021888161,0.00017576819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011130438,0.00004992326,0.9936811,0.00008737398,0.00006390533,0.00005454204,0.00028830045,0.000016265527,0.0005436672,0.000008789167,0.0000781269,0.0050165756],"study_design_scores_gemma":[0.0000043585483,0.00008652007,0.9994117,0.000014440806,0.000018575478,0.00019544718,0.00014803356,0.000015964588,0.000029597566,0.000013812615,0.00006033655,0.0000011688104],"about_ca_topic_score_codex":0.0013320049,"about_ca_topic_score_gemma":0.0022161808,"teacher_disagreement_score":0.0032801179,"about_ca_system_score_codex":0.000103122184,"about_ca_system_score_gemma":0.00013907505,"threshold_uncertainty_score":0.010973036},"labels":[],"label_agreement":null},{"id":"W4366263061","doi":"10.1177/20552173231167079","title":"Severity and worsening of fatigue among individuals with multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Janssen Research and Development","keywords":"Multiple sclerosis; Medicine; Depression (economics); Quality of life (healthcare); Physical therapy; Disease; Longitudinal study; Expanded Disability Status Scale; Chronic fatigue; Chronic fatigue syndrome; Psychiatry; Internal medicine; Pathology","score_opus":0.23898257523234614,"score_gpt":0.3865833825828719,"score_spread":0.14760080735052575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366263061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998511,0.00057775486,0.000024856654,0.00013598005,0.000005596458,0.000012091865,0.0002609295,0.0000029433884,0.0004689203],"genre_scores_gemma":[0.9993818,0.00018382598,0.000040756102,0.000042146152,0.000011627646,0.000008755448,0.00019124796,5.90763e-7,0.00013927417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970824,0.00009934486,0.00003967586,0.000051049672,0.000059216054,0.00004244802],"domain_scores_gemma":[0.99891305,0.00013844336,0.0006535976,0.00002849623,0.00011101714,0.00015536862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060760346,0.00015622647,0.0002522163,0.0006297886,0.00036343274,0.00029823696,0.00018157644,0.00036140205,0.0018662155],"category_scores_gemma":[0.0029751414,0.00011580754,0.00025032015,0.00055945065,0.00015317164,0.00046056093,0.0003084795,0.00034276498,0.00015935634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008583236,0.000030560954,0.99637586,0.000023109618,0.00003254754,0.000043689375,0.000113682065,0.00002290757,0.00011209905,0.0000046931236,0.00016481594,0.0029902076],"study_design_scores_gemma":[0.000003125638,0.0000701831,0.9995888,0.000008305944,0.000008331846,0.00011850377,0.000093789975,0.000022870787,0.000010797163,0.000008633728,0.000065345455,0.0000013147442],"about_ca_topic_score_codex":0.0035855202,"about_ca_topic_score_gemma":0.006955155,"teacher_disagreement_score":0.0035855202,"about_ca_system_score_codex":0.00023329174,"about_ca_system_score_gemma":0.0001776091,"threshold_uncertainty_score":0.0071293116},"labels":[],"label_agreement":null},{"id":"W4384831665","doi":"10.1177/20552173231188469","title":"Pain and participation in social activities in people with relapsing remitting and progressive multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; St. Michael's Hospital; University of Calgary; University of Manitoba","funders":"Canadian Institutes of Health Research; Institute of Musculoskeletal Health and Arthritis; Takeda Canada; Pfizer Canada; Sandoz Canada; Crohn's and Colitis Canada; Arthritis Society; Royal College of Physicians and Surgeons of Canada; Research Nova Scotia; Multiple Sclerosis Society; Research Manitoba; Mylan; Biogen; Janssen Canada; Amgen Canada; U.S. Department of Defense; Government of Alberta; AbbVie Canada; Multiple Sclerosis Society of Canada; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Multiple sclerosis; Relapsing remitting; Physical therapy; Medicine; McGill Pain Questionnaire; Expanded Disability Status Scale; Mood; Psychology; Clinical psychology; Visual analogue scale; Psychiatry","score_opus":0.17894582698084197,"score_gpt":0.4016830283170976,"score_spread":0.22273720133625566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384831665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983442,0.0009176478,0.000029440856,0.00012255786,0.0000043266446,0.000009235176,0.0002475671,0.0000017932151,0.00032323494],"genre_scores_gemma":[0.9994997,0.0001795873,0.000030256466,0.00003585035,0.00001125921,0.000009899688,0.00015407128,5.197499e-7,0.00007883547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999529,0.00013163743,0.00004349702,0.00007519454,0.00011941307,0.00010125095],"domain_scores_gemma":[0.9985661,0.00023647427,0.000864714,0.000031796626,0.00011516025,0.00018589546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065936823,0.00021802951,0.00038622887,0.00064288307,0.00033562072,0.00033334614,0.00028667226,0.00039342217,0.0018949808],"category_scores_gemma":[0.0029341928,0.0001389233,0.0003835813,0.00066997146,0.00025354477,0.00026738772,0.00050607004,0.0005710353,0.00015162188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014720988,0.000044367236,0.99628866,0.000035554396,0.00007378623,0.000054500495,0.00017587826,0.00002867043,0.000088210305,0.000012501113,0.00010275435,0.0029479372],"study_design_scores_gemma":[0.000004548981,0.00003338238,0.99968874,0.000007224447,0.000008106622,0.0000735349,0.00008425048,0.000040642226,0.0000059070144,0.000014695191,0.00003791861,0.0000010118961],"about_ca_topic_score_codex":0.0055803037,"about_ca_topic_score_gemma":0.0066113174,"teacher_disagreement_score":0.0055803037,"about_ca_system_score_codex":0.00024423745,"about_ca_system_score_gemma":0.00015046608,"threshold_uncertainty_score":0.011095643},"labels":[],"label_agreement":null},{"id":"W4386172465","doi":"10.1177/20552173231194352","title":"Sleep disturbance and fatigue in multiple sclerosis: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Medical Rehabilitation Research; National Institute on Minority Health and Health Disparities; Multiple Sclerosis Society; National Multiple Sclerosis Society","keywords":"Insomnia; Sleep (system call); Sleep disorder; Meta-analysis; Sleep onset; Sleep onset latency; Physical therapy; Medicine; Actigraphy; Psychology; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.5840726062392975,"score_gpt":0.47160494252181306,"score_spread":0.1124676637174844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386172465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018174038,0.9973099,0.00021024859,0.00009426575,0.000058106692,0.000158344,0.00021504266,0.000012681728,0.00012397714],"genre_scores_gemma":[0.045148704,0.9521718,0.0011261839,0.00031946524,0.000097391356,0.0005793,0.0003746014,0.000011001583,0.00017156078],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.995707,0.0017060874,0.0014229426,0.00039856805,0.0005996154,0.00016577404],"domain_scores_gemma":[0.98828435,0.0084843775,0.0017958232,0.00028336333,0.0009979537,0.0001541444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008385627,0.0021860995,0.014076315,0.006481268,0.00065834913,0.0024825777,0.0016606877,0.0017341495,0.003589831],"category_scores_gemma":[0.021454543,0.0011215258,0.023128005,0.007677778,0.0005305631,0.0015353893,0.0014267301,0.0013802068,0.00026596416],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083890924,0.000029357781,0.0027711224,0.7183977,0.24762757,0.00015282392,0.00010649313,0.00040074502,0.00022028273,0.00014014433,0.000933085,0.028381834],"study_design_scores_gemma":[0.00047771618,0.00025874632,0.0064422716,0.09874971,0.8893686,0.00024351328,0.000080841644,0.00020130862,0.00015887566,0.00022773693,0.0037578137,0.00003284133],"about_ca_topic_score_codex":0.008001457,"about_ca_topic_score_gemma":0.021319577,"teacher_disagreement_score":0.014076315,"about_ca_system_score_codex":0.0026427286,"about_ca_system_score_gemma":0.004572627,"threshold_uncertainty_score":0.044348},"labels":[],"label_agreement":null},{"id":"W4386192718","doi":"10.1177/20552173231195879","title":"Functional connectome fingerprinting and stability in multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Chugai Pharmaceutical; Humboldt-Universität zu Berlin; National Multiple Sclerosis Society; Deutsche Forschungsgemeinschaft; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Berlin Institute of Health; Biogen; Bayer; Arthur Arnstein Stiftung; Guthy-Jackson Charitable Foundation; Sanofi","keywords":"Connectome; Human Connectome Project; Resting state fMRI; Neuroscience; Multiple sclerosis; Default mode network; Cognition; Psychology; Functional connectivity; Identification (biology); Biology; Psychiatry","score_opus":0.35284724191698325,"score_gpt":0.34360571576774157,"score_spread":0.009241526149241674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386192718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99949336,0.00008805804,0.00019119764,0.000008040038,9.238574e-7,0.0000028965262,0.00010988618,0.0000041761004,0.00010134472],"genre_scores_gemma":[0.99969697,0.000023572817,0.00011343182,0.0000021437343,0.000002244032,0.0000034343657,0.000114696275,0.0000018440356,0.00004174771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998481,0.000029602104,0.00001965628,0.000052474563,0.000026267213,0.000023941808],"domain_scores_gemma":[0.9985178,0.00050634146,0.00061634416,0.00013520072,0.000118675096,0.000105628744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005957544,0.0002618468,0.00025208792,0.0010472573,0.00027780284,0.00042244646,0.00017751513,0.0003550072,0.0014598345],"category_scores_gemma":[0.0031326415,0.000114453476,0.00019484601,0.00047608386,0.00026357762,0.00046260402,0.00031955345,0.000272152,0.00016142384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006911217,0.000046984926,0.9825486,0.000024724466,0.00013049925,0.00027058748,0.00022526884,0.0005151221,0.0067370296,0.000059418195,0.000086863954,0.008663685],"study_design_scores_gemma":[0.0000035520509,0.00010282314,0.9977526,0.0000044089074,0.000022278922,0.00058436673,0.000052999025,0.000590049,0.000706036,0.0001194241,0.000056965437,0.0000044933363],"about_ca_topic_score_codex":0.0012778193,"about_ca_topic_score_gemma":0.002052795,"teacher_disagreement_score":0.0014598345,"about_ca_system_score_codex":0.00018910265,"about_ca_system_score_gemma":0.00011720399,"threshold_uncertainty_score":0.004883647},"labels":[],"label_agreement":null},{"id":"W4387477724","doi":"10.1177/20552173231203816","title":"Tolerability of subcutaneous ofatumumab with long-term exposure in relapsing multiple sclerosis","year":2023,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novartis Pharma","keywords":"Tolerability; Ofatumumab; Medicine; Teriflunomide; Adverse effect; Population; Incidence (geometry); Internal medicine; Multiple sclerosis; Rituximab; Fingolimod; Immunology; Environmental health","score_opus":0.18578832728008232,"score_gpt":0.37441799480282256,"score_spread":0.18862966752274024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387477724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99854857,0.00075681956,0.00023507852,0.000025947285,0.0000052999308,0.000021985039,0.00008834727,0.000009714785,0.0003081456],"genre_scores_gemma":[0.99949956,0.00015473936,0.00008475783,0.000022290511,0.000017177086,0.00001030658,0.00011463372,0.0000024703966,0.000094172996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940383,0.00017096534,0.00006288863,0.00007188446,0.00023116304,0.000059332826],"domain_scores_gemma":[0.9975344,0.00068611355,0.0013377877,0.00013270977,0.00016589562,0.00014312421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013359676,0.00020681629,0.0003981609,0.00019112071,0.00013410367,0.00032499494,0.00019129117,0.00022651923,0.0011992565],"category_scores_gemma":[0.0023041647,0.00008619696,0.00044199973,0.00025966452,0.00017124286,0.0002861196,0.00014768446,0.00046505456,0.00023893162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034911204,0.0026955095,0.66023374,0.00069187896,0.0012169599,0.0017826027,0.0006485528,0.0029787384,0.07192259,0.000059115097,0.0010141603,0.22184506],"study_design_scores_gemma":[0.00096895074,0.04755688,0.92854124,0.00005357639,0.00048641025,0.0059774737,0.0001426041,0.002489783,0.011945267,0.000103675775,0.0017134319,0.00002074291],"about_ca_topic_score_codex":0.00038193108,"about_ca_topic_score_gemma":0.00037511357,"teacher_disagreement_score":0.0013359676,"about_ca_system_score_codex":0.00027807947,"about_ca_system_score_gemma":0.00016369336,"threshold_uncertainty_score":0.007065356},"labels":[],"label_agreement":null},{"id":"W4393989530","doi":"10.1177/20552173241238627","title":"Subclinical atherosclerosis in multiple sclerosis","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Multiple Sclerosis Society of Canada; European Genomic Institute for Diabetes","keywords":"Medicine; Subclinical infection; Multiple sclerosis; Internal medicine; Logistic regression; Framingham Risk Score; Cardiology; Odds ratio; Disease; Immunology","score_opus":0.2987553641126069,"score_gpt":0.4099666718416961,"score_spread":0.11121130772908921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393989530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80584395,0.17840296,0.0015426666,0.0036479519,0.0003401726,0.00007920319,0.00065261836,0.00003920184,0.009451385],"genre_scores_gemma":[0.9823131,0.015882298,0.00060662103,0.00020941143,0.00043518448,0.00003946483,0.00015441119,0.000002232743,0.00035726905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908006,0.0004932462,0.00010229538,0.00008949786,0.00019493248,0.00003991141],"domain_scores_gemma":[0.9966264,0.0014323147,0.0012969197,0.00014285979,0.00026933936,0.00023227077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001971874,0.00027940053,0.00044088755,0.0013610033,0.0002648139,0.0006389971,0.00022013822,0.00031096637,0.0017395258],"category_scores_gemma":[0.0050638192,0.00012187985,0.00028356578,0.0012975829,0.00048512878,0.00034659758,0.0005121283,0.0005121241,0.00014998007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008683781,0.00022535045,0.88091034,0.0026548572,0.0006779124,0.00072308956,0.00062953774,0.00023686065,0.0019100218,0.0016519926,0.0023823997,0.10712929],"study_design_scores_gemma":[0.00006375218,0.00064618065,0.98675716,0.0005854074,0.00033650576,0.003243337,0.000220858,0.00029647702,0.00035083838,0.0028682095,0.0046191667,0.000012184003],"about_ca_topic_score_codex":0.0010752446,"about_ca_topic_score_gemma":0.0010579828,"teacher_disagreement_score":0.001971874,"about_ca_system_score_codex":0.00025025095,"about_ca_system_score_gemma":0.00061761757,"threshold_uncertainty_score":0.010428369},"labels":[],"label_agreement":null},{"id":"W4399018288","doi":"10.1177/20552173241247182","title":"Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"EMD Serono; National Research Foundation; Sanofi; European Commission; Biogen; Celgene; Alnylam Pharmaceuticals; International Progressive MS Alliance; Sanofi Genzyme; F. Hoffmann-La Roche; Monash University; Alexion Pharmaceuticals; Teva Pharmaceutical Industries; Universität Basel; Bristol-Myers Squibb","keywords":"Dimethyl fumarate; Chemistry; Pharmacology; Medicine; Immunology; Multiple sclerosis","score_opus":0.31401003087453827,"score_gpt":0.458550022342783,"score_spread":0.14453999146824476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399018288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5517176,0.43119463,0.0016514678,0.00221433,0.0007162112,0.0013006193,0.0070628254,0.00006902917,0.0040732343],"genre_scores_gemma":[0.941119,0.051632565,0.0019290203,0.0010027654,0.00045768046,0.0006974036,0.0027511525,0.000030343188,0.00037997594],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9783367,0.015633088,0.0026603227,0.0013628252,0.0016108098,0.00039621498],"domain_scores_gemma":[0.95341635,0.031230338,0.011376399,0.0017716287,0.0015111555,0.0006940783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020318452,0.0008963545,0.003620641,0.0012823732,0.0003184291,0.001825989,0.0014338824,0.0014306912,0.0043938695],"category_scores_gemma":[0.043688692,0.00048790104,0.009072224,0.0016332647,0.0010006664,0.0015321332,0.0011225786,0.0018396038,0.0003731615],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5031029,0.0020301968,0.047621906,0.060132887,0.22246188,0.00013445789,0.0003234384,0.0037723554,0.0007391061,0.0013351408,0.0028464606,0.15549923],"study_design_scores_gemma":[0.29876772,0.10917856,0.1512221,0.02519722,0.37865922,0.00074594695,0.0006501499,0.0054461537,0.0020879433,0.0039532576,0.02382077,0.00027102564],"about_ca_topic_score_codex":0.0026475377,"about_ca_topic_score_gemma":0.00346078,"teacher_disagreement_score":0.020318452,"about_ca_system_score_codex":0.0016747604,"about_ca_system_score_gemma":0.0012025561,"threshold_uncertainty_score":0.10745549},"labels":[],"label_agreement":null},{"id":"W4403215541","doi":"10.1177/20552173241285546","title":"Cesarian sections in women with multiple sclerosis: A Canadian prospective pregnancy study","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital; University of Alberta; University of British Columbia","funders":"Multiple Sclerosis Society of Canada; Biogen","keywords":"Pregnancy; Multiple sclerosis; Obstetrics; Prospective cohort study; Medicine; Psychiatry; Surgery; Biology","score_opus":0.13388811882265836,"score_gpt":0.36428925077724045,"score_spread":0.2304011319545821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403215541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99181116,0.0015954758,0.00007853978,0.0004962708,0.000017484279,0.000080234015,0.0027448381,0.000006646519,0.0031692279],"genre_scores_gemma":[0.9961708,0.0018388096,0.00015948879,0.0001952637,0.000009459618,0.000034626206,0.0011060406,0.00000482951,0.00048062886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993857,0.00006104509,0.000043927128,0.00011613014,0.00023192883,0.00016117816],"domain_scores_gemma":[0.9988617,0.00010877546,0.00038699308,0.0000634484,0.00028423208,0.00029485897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006838858,0.00027152017,0.00028911734,0.0009523423,0.0019111125,0.0007294324,0.0007340516,0.0005435173,0.0021942474],"category_scores_gemma":[0.002698348,0.00039888572,0.00034592283,0.0025283585,0.00045130544,0.00035561877,0.0005806374,0.0008675031,0.00022209638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096446194,0.000029480705,0.99627775,0.000027304332,0.000029888439,0.00018842144,0.00029289935,0.000021732176,0.00009985576,0.00007323825,0.000548948,0.0023140488],"study_design_scores_gemma":[0.000012566974,0.000036913676,0.9983581,0.00004577987,0.000025730362,0.00029653462,0.0004949817,0.00008488846,0.000026569647,0.000020894371,0.00058924494,0.000007858109],"about_ca_topic_score_codex":0.8678865,"about_ca_topic_score_gemma":0.84310645,"teacher_disagreement_score":0.13211352,"about_ca_system_score_codex":0.004869594,"about_ca_system_score_gemma":0.007694311,"threshold_uncertainty_score":0.26578307},"labels":[],"label_agreement":null},{"id":"W4405090465","doi":"10.1177/20552173241301030","title":"Heterogeneity of aerobic fitness changes with exercise training in progressive multiple sclerosis: Secondary, exploratory analysis of data from the CogEx trial","year":2024,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; European Genomic Institute for Diabetes","keywords":"Aerobic exercise; Multiple sclerosis; Physical medicine and rehabilitation; Psychology; Exploratory analysis; Physical therapy; Medicine; Gerontology; Data science; Computer science; Psychiatry","score_opus":0.3900389121474257,"score_gpt":0.42241183084893635,"score_spread":0.032372918701510656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405090465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9311083,0.028183402,0.013128,0.0010307091,0.00035278383,0.013251161,0.009688966,0.000246924,0.00300976],"genre_scores_gemma":[0.9869069,0.00091037276,0.0028591387,0.0004984118,0.00015984802,0.005806001,0.0024167956,0.00004637181,0.00039609897],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9112546,0.071512416,0.0076913238,0.0035448668,0.0046621086,0.0013347042],"domain_scores_gemma":[0.89166665,0.079220876,0.016353054,0.008051926,0.0036543405,0.0010531744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.059232417,0.0019926499,0.0062971637,0.0016539603,0.00050321204,0.0020065354,0.0012510433,0.0018553761,0.0041127815],"category_scores_gemma":[0.09771414,0.0005172214,0.012941927,0.0016723273,0.0011078317,0.0013621185,0.0022101325,0.0013780621,0.00028574993],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5546196,0.0022096275,0.09333157,0.02820482,0.24289346,0.0010477889,0.0016219568,0.0040988084,0.0068138414,0.001062448,0.004683268,0.059412938],"study_design_scores_gemma":[0.16102731,0.09417036,0.47288322,0.0044706226,0.23202614,0.0017720372,0.001252742,0.008409277,0.006453421,0.00629972,0.010766379,0.00046882892],"about_ca_topic_score_codex":0.00068327965,"about_ca_topic_score_gemma":0.0009290613,"teacher_disagreement_score":0.059232417,"about_ca_system_score_codex":0.0008030338,"about_ca_system_score_gemma":0.0014520101,"threshold_uncertainty_score":0.3132547},"labels":[],"label_agreement":null},{"id":"W4407040978","doi":"10.1177/20552173251315161","title":"Disproportional smaller fornix with altered microstructure in pediatric multiple sclerosis shown by high-resolution fluid-suppressed diffusion tractography","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Fornix; Diffusion MRI; Fractional anisotropy; White matter; Tractography; Hippocampus; Medicine; Nuclear medicine; Neuroscience; Psychology; Internal medicine; Magnetic resonance imaging; Radiology","score_opus":0.06604719742723783,"score_gpt":0.32421021881174383,"score_spread":0.258163021384506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407040978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993544,0.00010617515,0.00023976873,0.000017801276,0.0000020449934,0.0000050362155,0.000070184455,0.000011329671,0.00019321805],"genre_scores_gemma":[0.9991179,0.000111338624,0.00053655036,0.000011639519,0.000005876409,0.0000058693468,0.00010665577,0.0000069180496,0.000097333985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998337,0.00001823023,0.00001728819,0.000062162355,0.000035784844,0.000032787386],"domain_scores_gemma":[0.9992093,0.00007350189,0.0005253216,0.000031548552,0.000068938876,0.00009142844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028603943,0.0006225858,0.00032051455,0.0010356456,0.00028974452,0.00035708246,0.00019205913,0.0003610114,0.0017289789],"category_scores_gemma":[0.00095193816,0.0002440587,0.00023446642,0.00057636364,0.00068771414,0.00040498324,0.00029840053,0.000273107,0.00020769487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046184918,0.00005005598,0.9492166,0.00008860876,0.000062461586,0.01335901,0.00039165918,0.00030029123,0.028931908,0.00016068648,0.00022759555,0.0067493976],"study_design_scores_gemma":[0.000012182797,0.00020658983,0.9672262,0.000016128244,0.000036798057,0.028889567,0.00018822313,0.00031446677,0.0027841674,0.00006935795,0.00025113835,0.0000053206713],"about_ca_topic_score_codex":0.002686015,"about_ca_topic_score_gemma":0.0026346094,"teacher_disagreement_score":0.002686015,"about_ca_system_score_codex":0.00033176315,"about_ca_system_score_gemma":0.00037876767,"threshold_uncertainty_score":0.0057840347},"labels":[],"label_agreement":null},{"id":"W4408523255","doi":"10.1177/20552173251321814","title":"Characterizing the diversity of the multiple sclerosis population in Canada: A scoping review","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of British Columbia; St. Michael's Hospital; University of Waterloo; Queen's University; University of Manitoba; University of Toronto; Dalhousie University","funders":"Multiple Sclerosis Society of Canada","keywords":"CINAHL; MEDLINE; Medicine; Scopus; Population; Family medicine; Health care; Gerontology; Nursing; Environmental health; Psychological intervention","score_opus":0.3078140036118556,"score_gpt":0.41723195738932256,"score_spread":0.10941795377746694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408523255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037581197,0.98946023,0.0002706779,0.0018155497,0.00015954013,0.0006508396,0.0022051546,0.000013338577,0.0016665679],"genre_scores_gemma":[0.047349863,0.9467102,0.0018255356,0.0012426213,0.000095870666,0.0010609492,0.0014436657,0.00001203244,0.00025927206],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97831935,0.0040239645,0.00797063,0.0015735381,0.006842423,0.0012702156],"domain_scores_gemma":[0.88931143,0.0592524,0.014050828,0.0016458859,0.03371777,0.0020216794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02756164,0.0012207562,0.0053808866,0.04544584,0.0050309505,0.010172216,0.0032071795,0.0025816446,0.002576228],"category_scores_gemma":[0.11220118,0.001247565,0.00292854,0.07640636,0.0035893568,0.0041883886,0.0030955914,0.0015347411,0.00025311438],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021032743,0.000043186337,0.020879006,0.73849636,0.003317728,0.00047762293,0.0061132647,0.0004921062,0.000376607,0.0020545924,0.012122582,0.21541664],"study_design_scores_gemma":[0.000045151493,0.00005475949,0.040574092,0.89966434,0.008186776,0.00038978242,0.00452154,0.00016189169,0.00019185826,0.0005489976,0.04558374,0.00007701637],"about_ca_topic_score_codex":0.827332,"about_ca_topic_score_gemma":0.89947826,"teacher_disagreement_score":0.17266798,"about_ca_system_score_codex":0.05664394,"about_ca_system_score_gemma":0.2419132,"threshold_uncertainty_score":0.4109825},"labels":[],"label_agreement":null},{"id":"W4412016986","doi":"10.1177/20552173251355677","title":"Delphi panel to understand the real-world occurrence and management of ofatumumab injection-related reactions among healthcare providers of people with relapsing multiple sclerosis","year":2025,"lang":"en","type":"article","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"Novartis Pharmaceuticals Corporation","keywords":"Ofatumumab; Medicine; Delphi method; Delphi; Clinical Practice; Health care; Family medicine; Physical therapy; Demographics; Internal medicine; CD20","score_opus":0.1938430667576781,"score_gpt":0.38737886802890953,"score_spread":0.19353580127123143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412016986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77952856,0.0021260371,0.033825032,0.10275108,0.0018673727,0.029374918,0.0009955812,0.0002470791,0.049284387],"genre_scores_gemma":[0.9221401,0.0015102326,0.038241494,0.018239293,0.00026461924,0.016282575,0.00022916005,0.0000407706,0.0030518316],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.93864757,0.05176206,0.0025426834,0.0009830962,0.002761564,0.003303007],"domain_scores_gemma":[0.93903995,0.040580574,0.0033109963,0.0017834882,0.01070224,0.0045827357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.069875814,0.0007074525,0.0004195671,0.0012051235,0.0039814473,0.001912632,0.0012096207,0.0028217447,0.008693129],"category_scores_gemma":[0.08473612,0.0006646512,0.0008939017,0.0007020192,0.002503343,0.0031757138,0.008610633,0.0038289155,0.001078153],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012289868,0.0011283415,0.04070765,0.004080229,0.00019495025,0.0025109397,0.66103756,0.0018436507,0.012120356,0.012629638,0.110278,0.15223965],"study_design_scores_gemma":[0.0004994498,0.0020714807,0.039746232,0.0048717563,0.00011282824,0.003499485,0.7253807,0.0059539573,0.0032061092,0.013976742,0.20024204,0.0004391837],"about_ca_topic_score_codex":0.0019329239,"about_ca_topic_score_gemma":0.0022871352,"teacher_disagreement_score":0.069875814,"about_ca_system_score_codex":0.003930651,"about_ca_system_score_gemma":0.008967329,"threshold_uncertainty_score":0.36954302},"labels":[],"label_agreement":null},{"id":"W4415671084","doi":"10.1177/20552173251390649","title":"Safety reporting quality in multiple sclerosis clinical trials: A review of phase III clinical trials included in FDA approval of disease-modifying treatments","year":2025,"lang":"en","type":"review","venue":"Multiple Sclerosis Journal - Experimental Translational and Clinical","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; International Collaboration On Repair Discoveries; University of Toronto; University of British Columbia","funders":"","keywords":"Clinical trial; Multiple sclerosis; Quality (philosophy); Phase (matter); Phases of clinical research; MEDLINE; Fingolimod","score_opus":0.8083518433804945,"score_gpt":0.6390472112166301,"score_spread":0.16930463216386438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415671084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048988545,0.99536777,0.001487898,0.0014300443,0.00028348056,0.00042703777,0.0001577494,0.000019496372,0.00033672625],"genre_scores_gemma":[0.014274384,0.9752666,0.007190581,0.0012003586,0.00030778936,0.0013351666,0.00027719766,0.000025801552,0.000122116],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.7644875,0.11582817,0.081889175,0.005402373,0.031421468,0.00097127736],"domain_scores_gemma":[0.45458013,0.39815906,0.097252436,0.0094976695,0.039013837,0.0014968374],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21472363,0.001623229,0.0074069505,0.014384317,0.0009676956,0.0050570276,0.003154438,0.0028726563,0.0017958311],"category_scores_gemma":[0.34831765,0.0013940174,0.006833666,0.01931532,0.003092607,0.0045344154,0.0026371565,0.0027094267,0.00034491598],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053836236,0.000049288457,0.0034186817,0.46017677,0.0053122807,0.00009595819,0.00074693584,0.00042343987,0.0005018647,0.0022685593,0.007302283,0.5191656],"study_design_scores_gemma":[0.00063952664,0.0006290607,0.0136146005,0.81906354,0.025014114,0.00091090484,0.00076220086,0.00072899467,0.0014305324,0.004403653,0.13266397,0.00013889965],"about_ca_topic_score_codex":0.0030696003,"about_ca_topic_score_gemma":0.0047499086,"teacher_disagreement_score":0.78527635,"about_ca_system_score_codex":0.0063523245,"about_ca_system_score_gemma":0.020238535,"threshold_uncertainty_score":0.9683856},"labels":[],"label_agreement":null}]}